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ABSTRACT
THE ROLE OF STEM CELLS IN ADIPOSE TISSUE REMODELING
Candice ReShay Holden
November 25, 2014
The work presented in this dissertation outlines the role of stem cells in
the remodeling of adipose tissue under conditions of nutrient excess. Obesityinduced variations in adipose tissue stem cell distribution were uncovered by
analysis of the stromal vascular fraction isolated from mice fed a high fat diet for
several weeks. Bone marrow cell transplantation was used to determine the
derivation of progenitor cells found in adipose tissue; and supplementation of
depleted progenitor cell populations achieved via direct cell transplantation,
helped to determine the contribution of these progenitor cells to the remodeling
process.
The dissertation is presented in five chapters outlining the adipose tissue
remodeling process, metabolic changes which occur in adipose tissue in
response to nutrient excess, diet-induced variations in adipose tissue stem cell
distribution, and the impact of stem cell transplantation on remodeling of adipose
tissue. Chapter one serves as a general introduction defining the development of
obesity, health implications of obesity and methods by which adipose tissue can
remodel in response to nutrient excess. Chapter two describes the metabolic
changes that occur within visceral adipose tissue upon consumption of high fat
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diet. The third chapter details changes in adipose tissue stem cell distribution in
response to nutrient excess. The studies presented in chapter three suggest that
obesity is associated with an imbalance in adipocyte and endothelial progenitor
cells. This imbalance was corrected to determine if doing so was sufficient to
ameliorate obesity-associated complications and data from these studies are
presented in chapter four. Finally, a comprehensive discussion of the implications
of these studies is outlined in chapter five.
Chapters two and three focus on the impact of high fat diet on the
metabolic profile of adipose tissue and distribution of adipose tissue stem cells.
Chapter four centers on correcting the progenitor cell ratio, skewed by
consumption of high fat diet. The studies presented in the fourth chapter suggest
increasing the endothelial progenitor cell population promotes cell engraftment
into vasculature of the adipose tissue. Increasing the capacity of these cells
further supports vessel formation and engraftment in obese tissue and may
therefore offer insight into potential therapeutic treatments.
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CHAPTER 1
GENERAL INTRODUCTION

Obesity epidemic in the United States
Climbing rate of obesity
The prevalence of obesity in the United States has increased remarkably
over the past four decades (1, 2). The National Health and Nutrition Examination
Survey reported the prevalence of obesity in the United States as 15% from 1976
to 1980 (1). Between the years of 1988 and 1994, the Centers for Disease
Control (CDC) reported that the prevalence of obesity was approximately 22.9%.
By the year 2000, the prevalence of obesity was reported to be 30.5% and, in
2010, that statistic increased again to 35.7% (3-6). It was recently reported that,
in the United States, 34.9% of individuals over the age of 20 are currently obese
(7). In the state of Kentucky, 31.3% of the population is considered obese (4).
The high prevalence of obesity is important because it increases the incidence of
pre-diabetic and diabetic states and is associated with numerous co-morbidities.
As such, a substantial financial burden, due to obesity, has been imparted on the
economy of the United States. Most recent estimates suggest that $147 billion
US dollars are spent on the treatment of obesity with obese individuals paying an
additional $1,429 each year for medical treatment (8)!
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Potential causes for this relatively recent increase in obesity prevalence
are low levels of physical activity and increased caloric intake. The CDC reports
that only 48% of adults meet the guidelines for physical activity, i.e., 30 minutes
of moderate activity or endurance training 5 days per week or 20 minutes of
vigorous activity 3 days per week (9, 10). In Kentucky, where the obesity
prevalence is above 30%, only 17.7% of the state’s surveyed population were in
compliance with the CDC’s physical activity recommendations in 2000 (4, 11). In
2003-2004, the CDC sampled 1,714 adults and reported that only 3% of nonsleeping time was spent exercising, 58% of the day was spent in sedentary
behavior and 39% was spent engaging in a light-intensity activity (12).
Hyperphagia and consumption of a diet rich in fat, are also known to
contribute to the development of obesity (13-15), and, expectedly, physical
inactivity combined with the consumption of excess nutrients exacerbates the
obese condition (11). Excess lipids are deposited in peripheral organs and this
ectopic deposition of fat has been implicated in the development of several
chronic disease states (16). Ectopic fat deposition in organs such as the skeletal
muscle, pancreas, and liver has been shown to result in glucose intolerance,
hyperinsulinemia, and hyperlipidemia (16, 17). Though diet-induced obesity is
the predominant focus of our work, there is also a wealth of evidence to suggest
that genetic makeup could also play a role in the determination of body
composition (13, 18-21).
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Definition and Diagnosis of obesity
Obesity develops as caloric intake consistently exceeds energy
expenditure generating a surplus of nutrients which are not used for biological
processes and are stored as esterified fat. This condition has been classically
defined as having a body mass index (BMI) > 30. With the rate of obesity steadily
rising, in November of 2013, the American Medical Association suggested that
obesity should be acknowledged as a disease and should be treated as such.
This would include physicians advising patients to utilize weight loss programs as
a means to avoid obesity-related complications and to improve and potentially
alleviate any pre-existing conditions related to increased adiposity (22).
BMI is calculated using body weight and height (Scheme 1). It provides an
estimate of the body fat content of an individual. Using a BMI measurement as
the sole method for quantification of body fat content could lead to an inaccurate
estimation for exceptionally tall individuals over 7 feet in height, those with
decreased muscle mass such as the elderly, those with increased muscle mass
such as athletes, and pregnant woman. To more accurately assess body fat,
multiple measurements should be made.
There are several ways to measure body fat, including measurement of
waist circumference, skin calipers, bioelectrical impedance, and Dual-energy Xray Absorptiometry or Dexascan. Measurements of waist circumference and
bioelectrical impedance are relatively simple to obtain. According to the National
Institutes of Health (NIH), women with a waist circumference > 35 inches or men
measuring > 40 inches show increased risk for obesity-related diseases.
3

Bioelectrical impedance utilizes gentle electrical impulses and the difference in
conductivity of fat and muscle to discriminate between lean mass and fat mass.
Calipers can be used be used to measure body fat. For this, the skin is pinched
in several locations and the thickness of the skin flap is measured. Calipers can
be used on the arm, abdominal region, thighs, and several other locations. The
measurements from each of these regions along with the individual’s age can
then be used in an algorithm to calculate body fat. This algorithm utilizes the
Jackson-Pollack and Siri equations as described in Scheme 1 (23-25). Tools to
complete all of these assessments are readily available.
Dexascan, the most accurate and costly of the techniques presented here,
takes very little time to complete and is painless to the subject, however it cannot
be measured at home. For this, the subject undergoes a fairly standard X-ray
procedure and the bone, fat, and lean mass can be calculated based upon the
absorption of x-rays in each tissue type (26).

4

Scheme 1
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Scheme 1. Calculation of body mass index and body fat percentage using
skin calipers. The equation for the calculation requires a measurement of total
body weight and height as outlined above, (A). Total body density is first
calculated using the Jackson-Pollack equation which is gender specific. The Siri
equation, which can be applied to both males and females, is then used to
determine the body fat percentage, (B).
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Function and types of adipose tissue
It has been suggested that adipose tissue is a major regulator of metabolic
homeostasis. This is partly via its chief function, which is to esterify free fatty
acids (FFA) and store excess lipids as triglycerides to serve as a reserve energy
source (16). The ability to compile a nutrient reserve from excess caloric intake is
conserved across several species (21, 27, 28). In humans, fat is stored in
visceral and subcutaneous white adipose tissue depots which are located in
several areas of the body. Visceral depots are most often found in the abdominal
region, surrounding the intestines and kidneys. Subcutaneous depots are located
just beneath the skin and pads in the abdominal area, buttocks, and thighs are
most substantially expanded due to nutrient overload. Distribution of fat changes
with age, typically increasing more in the visceral abdominal region (27). Insulin
resistance occurs when fat can no longer be accommodated by these depots and
begins to accumulate in non-adipose organs such as skeletal muscle, liver,
kidneys, and the heart (16).
Though white adipose tissue is the most abundant fat source in adults,
brown and beige adipose tissues also function to maintain metabolic stability.
Brown fat is also believed to originate from the mesoderm and is a highly active
tissue (27). The primary function of brown adipose tissue is thermogenesis. In
newborns there is an increased amount of brown fat that is significantly
decreased with age. This tissue helps to maintain basal body temperature and
can be stimulated to increase energy expenditure and produce heat in times of
need with the support of uncoupling protein-1 (UCP-1) located in the
7

mitochondrial membrane (29). In conditions where brown adipose tissue is not
present, diet-induced obesity, diabetes, and hyperlipidemia have been observed
(30).
White adipose tissue has been shown to dedifferentiate and change to a
more “brown-like” phenotype due to extended exposure to cold or increased
sympathetic stimulation (27, 31-33). UCP-1 positive cells appear to be dispersed
throughout white adipose depots. More recently, these cells have been called
“beige” adipocytes. These cells have a lineage consistent with that of white
adipocytes but express UCP-1 and generate heat upon stimulation (17, 23-26).
UCP-1 expression has also been observed to increase with the use of
thiazolidinediones (TZDs) (34).
Adipose tissue composition and progenitor identification
Adipose tissue is composed of a multitude of cells, the functional cell type
being adipocytes. Mature or terminally differentiated adipocytes can easily be
identified by immunohistological staining for the protein perilipin. Perilipin is found
in the thin cell membrane of the adipocyte. Oil Red-O and Nile red dyes can be
used to identify lipid droplets within the mature adipocytes. In white adipose
tissue, these droplets are large and unilocular, unlike those of brown adipose
tissue which are multilocular in nature. As previously described, brown
adipocytes express UCP-1 whereas white adipocytes are leptin positive. Both
white and brown mature adipocytes express Peroxisome Proliferator- Activated
Receptor gamma 2 (PPARƔ2), Glucose Transporter Type 4 (GLUT4), fatty acid
synthase, and are regulated by insulin (27, 35).
8

When adipose tissue is digested using collagenase to isolate specific cell
types of interest, lipid-loaded adipocytes float due to decreased density. The
mixture of cells which can be pelleted is referred to as the stromal vascular
fraction (SVF). The SVF contains mesenchymal stem cells including
preadipocytes, vascular/endothelial progenitor cells, pericytes, dendritic cells,
fibroblasts, mature endothelial cells, immune cells such as macrophages, T cells,
B cells, and monocytes as well as a host of other cell types (36). Preadipocytes
or adipocyte progenitor cells can be distinguished by the expression of CD29,
CD24, CD34, and stem cell antigen-1 (Sca-1).
In 2008, Rodeheffer, et al. showed that progenitor cells were sorted from
the SVF based upon their expression profile of cell surface antigens for CD24,
CD29, CD34, CD31, Sca-1 and lineage marker (Lin). Four cell types were
isolated and cultured for in vitro analysis. Cultures enriched for cells positive for
CD29, CD34, and CD24 and negative for CD31 and the lineage marker (Lin)
showed a significant increase in Oil Red-O staining compared to unfractionated
SVF. However, when expression levels of adipsin and aP2 were quantified, cells
which were positive for CD24 in addition to CD29, CD34, and Sca-1 and negative
for CD31 and the lineage marker (Lin) had the highest levels of expression for
both adipocyte markers. When CD24, CD29, CD34, Sca-1 positive and CD31
and Lin negative cells were transplanted into insulin resistant A-Zip mice lacking
functional epididymal white adipose tissue, the cells were able to proliferate and
form a functional fad pad similar in size to that of a normal, wild-type mouse just
12 weeks after injection of 50, 000 cells. Systemically, plasma insulin and
9

glucose levels decreased to the level of the wild-type and adiponectin levels were
increased. The cells were harvested from mice expressing green fluorescent
protein (GFP) and after completion of the study, the fat pads harvested from the
transplanted A-Zip mice were identified as GFP positive, unilocular, lipid-loaded
cells (37).
Adipose tissue deficiency: Lipodystrophies
Although more than one-third of the US population struggles with obesity,
a smaller amount of Americans, less than 200,000 people, have the opposite
problem and are unable to store fat properly. This is a rare condition described
by the NIH-Office of Rare Diseases as lipodystrophy. This disease can be
attributed to a marked decrease in leptin, utilization of certain drug therapies
such as antiretroviral drugs which are commonly used for the treatment of HIV, or
genetic predisposition (38).
Several types of lipodystrophy can be attributed to genetics (39, 40).
Mutations in genes encoding for PPARƔ, AGPAT2, AKT2, CAV1, PTRF, CIDEC,
lamin A/C, ZMPSTE24, and BSCL2 are some of the causes for the development
lipodystrophy. These mutations can cause problems in the development,
differentiation, or lead to the premature death of adipocytes. Due to the inability
to properly store fat, individuals with lipodystrophy are predisposed to diabetes,
pancreatitis, end stage renal disease, diabetic retinopathy, CHD, renal failure,
and even arrhythmias which could induce sudden death. Currently, the only
approved treatments for individuals with this disease work to decrease excess
visceral adiposity. There is not much that is currently offered to alter fat storage
10

in lipodystrophy individuals, such a treatment might create a more favorable, less
pathogenic distribution of fat (40).

Health implications and consequences of obesity
Insufficient amount of physical activity and increased in caloric intake are
major contributors to the rise of obesity in American adults. The development of
obesity

is

associated

with

several

complications.

Obesity-

associated

complications include, but are not limited to: insulin resistance, Type 2 Diabetes
(T2D), predisposition for certain cancers, hypertension, dyslipidemia, metabolic
syndrome, stroke, and coronary heart disease (10, 41-46).
Coronary heart disease (CHD) is defined as the development of plaques
in coronary arteries which may impede blood flow as they become larger over
time. This decrease in blood supply could lead to angina, heart attack and
arrhythmias.

There is evidence that increasing aerobic activity beyond the

amount specified in guidelines set by the American Heart Association (AHA) and
American College of Sports Medicine has potential health benefits and can
reduce the risk for CHD (10). The National Runners’ Health Study provided
information from a cohort of 8,283 runners in which the amount of self-reported
weekly physical activity was strongly correlated with biomarkers of physical
activity such as increased high-density lipoprotein (HDL), reduction of
hypertension, lower blood pressure, decreased adiposity, lower triglyceride level,
and decrease CHD risk (41). After 10 years, a follow-up survey was administered
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to the group inquiring about the need for or completion of coronary artery bypass
surgery and percutaneous transluminal coronary angioplasty as well as
information about the number of heart attack and angina diagnoses experienced
by the study participants. This assessment revealed the correlation of running
and the reduction of CHD risk could be mediated by the baseline BMI of the
individual, suggesting that running may be of greater benefit to individuals with a
higher BMI than those with a lower BMI at baseline. However, higher baseline
BMI significantly increased the risk for the development of CHD, hypertension,
high cholesterol, and diabetes; even in those that engaged in vigorous physical
actively on a regular basis (10).
There have been numerous studies implicating obesity as a confounding
factor for the development of Type 2 Diabetes (T2D) and insulin resistance (4246). The underlying cause being adipocyte dysfunction and increased caloric
intake for both T2D and insulin resistance offers support for the association
between the conditions and the development of obesity. It has also been
established that adipose tissue is a major regulator of systemic glucose and lipid
homeostasis.
Obesity can induce both changes in metabolism within adipocytes
themselves and more broad changes in the adipose tissue as whole. Diet
induced-obesity has been shown to cause a decline in mitochondrial abundance
in white adipocytes over time (47-50). This phenomenon has been described as
adipose tissue “whitening” (15, 51, 52). The dynamic nature of adipose tissue
allows adipocytes to change phenotype along a continuum with highly
12

metabolically active brown adipocytes at one end and white adipocytes with
decreased metabolic activity at the other (15, 53). Metabolic changes that occur
during the whitening process have not been completely described; however, our
metabolomic analyses have revealed that diet-induced metabolic changes
precede adipose tissue inflammation and loss of mitochondria in visceral adipose
tissue. These changes appear to coincide with perturbations of lipid, amino acid,
glucose, and energy metabolism, posing a threat to systemic metabolic
homeostasis (15).
As previous stated, consumption of HF diet can also cause dysfunction in
adipose tissue as a whole. Under conditions of nutrient excess, some adipocytes
expand to sizes as large as 10,000µm² (54). Such expansion requires extreme
remodeling of the adipose tissue microenvironment. Adipocyte expansion at that
level can lead to hypoxia due to the inability of oxygen to diffuse such a great
distance from the capillary and cell necrosis once the adipocytes hypertrophy
pass the point of sustainability (55-58). Hypertrophied adipocytes can secrete a
host of pro-inflammatory cytokines and chemokines including macrophage
chemoattractant protein (MCP-1). This results in the recruitment of inflammatory
cells to clear dead cells (58, 59). Influx of inflammatory cells like macrophages
and T cells, creates a state of low-grade chronic inflammation. Tumor necrosis
factor-α (TNFα) is also increased in inflamed adipose tissue spurring more
recruitment of inflammatory cells and disrupting the lipid storage process leading
to insulin resistance. Together, these events are indicative of unfavorable,
pathological adipose tissue remodeling (42, 56, 60, 61).
13

Metabolically favorable adipose tissue remodeling
A major remodeling of the adipose tissue is believed to occur after
resolution of the necrosis-induced inflammatory response associated with
excessive adipocyte hypertrophy. This phenomenon has been coined the
“necrotic wave”. After resolution of inflammation, progenitor cells in the adipose
tissue proliferate, differentiate, and repopulate the organ. This is associated with
restoration of insulin sensitivity and is known as favorable adipose tissue
remodeling (56).
Increased storage capacity of the white adipose tissue depots appears to
be beneficial to systemic metabolism. An increase in fat storage capacity
decreases ectopic storage of excess lipids in peripheral organs, which appears to
prevent insulin resistance. One such example, was reported by Dr. Philipp
Scherer’s group. They studied transgenic mice overexpressing adiponectin. The
mice presented a phenotype of healthy, morbid obesity. The group proposed that
the increase in adiponectin served as somewhat of a starvation signal, prompting
the body to store esterified fat in the adipose tissue as opposed to peripheral
organs. In so doing, there was no substantial ectopic deposition of fat which
allowed for the preservation of insulin sensitivity and metabolic homeostasis in
the transgenic mice (41).
Likewise, obese (ob/ob) mice expressing a mitochondrial membrane
protein called MitoNEET have the capacity to store enormous amounts of fat
while still maintaining systemic insulin senstivity and preventing adipose tissue
inflammation. MitoNEET exists in the outer mitochondrial membrane and
14

functions to increase the overall activity of the mitochondria, stimulate
adiponectin production, and decrease damage due to reactive oxygen species.
Mice overexpressing this gene can therefore store a tremendous amount of lipid
in their white adipose tissue depots (62).

In both cases, the mice become

morbidly obese with body weights as high as 130 grams, yet metabolic
homeostasis was not disturbed.
In both metabolically normal, obese transgenic mouse models, the
adipose tissue consists of numerous small adipocytes which have been shown to
derive from adipocyte precursor cells (37, 62, 63). The presence of smaller
adipocytes have been shown to correlate with increased lipid storage capacity
and increased mitochondrial density promoting metabolically favorable adipose
tissue remodeling (64). Perhaps availability of adipocyte precursors with
increased proliferative and differentiation capacity could be important in
promoting favorable metabolic remodeling under conditions of nutrient excess.

Adipose tissue stem cells
Origin and regulation
Fat is believed to have originated from the mesoderm in humans, similar
to bone and muscle tissues. Mesenchymal stem cells (MSCs), found in bone
marrow, also have mesodermal lineage and upon differentiation, these cells have
the capacity to differentiate into adipocytes, osteoblasts, chondrocytes,
myoblasts, and connective tissue (27). Cells that give rise to mature adipocytes
15

are known as preadipocytes or adipocyte progenitor cells. Though the specific
number of steps in the differentiation process of a MSC to a mature adipocyte is
unclear, Spiegelman and Rosen propose that there are four distinct stages in the
maturation process of murine preadipocytes. These stages are growth arrest,
clonal expansion, early differentiation, and terminal differentiation (65). Each of
these steps can be transcriptional regulated impacting differentiation and
maturation of the adipocyte. Major contributors to these processes are PPARƔ
and C/EBP.
As previously discussed, mesenchymal stem cells expressing CD24,
CD29, CD34, and Sca-1 can give rise to mature adipocytes in vivo, but these
cells have been shown to lose expression of CD24 after commitment to the
adipocyte lineage. It was reported that 4 days after transplantation of CD24
positive preadipocytes into A-Zip mice, 91.4% of the transplanted cells were
negative for CD24 after analysis by flow cytometry (37, 66). This could prove to
be an issue in tracking these newly modified cells. Interestingly, the CD24
negative cells showed increased expression levels of adipocyte markers like
PPARƔ and C/EBPα.
PPARƔ has been shown to have the most profound effect on adipocyte
differentiation. Without adequate expression of the transcription factor, cells will
not terminally differentiate and in some cases, may even dedifferentiate, resulting
in lipid unloading and a decline in adipocyte marker expression. There are two
PPARƔ isoforms, PPARƔ1 and PPARƔ2. PPARƔ2 is an accepted adipocytespecific marker, though in cases when PPARƔ2 is unavailable, PPARƔ1 has
16

been shown to be unregulated in an attempt to maintain metabolic homeostasis.
In mice without the gene for PPARƔ2, adipogenesis is decreased as well as
insulin sensitivity (27, 35). C/EBP is a family of transcription factors including
CHOP, C/EBPα, C/EBPβ, C/EBPδ, and C/EBPƔ; C/EBPα having the most
profound impact on adipogenesis in white adipose tissue (27). Without C/EBPα,
mice developed hypertrophied brown adipocytes and were unable to form mature
white adipose tissue in both subcutaneous and visceral depots (67).
Specific cells of interest
Our work has been focused on the role of adipose progenitor and
endothelial progenitor cells. Both cell types have been shown to have
regenerative capacity, improving peripheral blood flow (68, 69) and repopulating
the adipose tissue during the remodeling process (56). As previously stated,
mesenchymal stem cells of the adipose tissue commit to the adipocyte lineage
and are then named adipocyte progenitors or preadipocytes. The commitment of
these cells is transcriptionally regulated in large part by PPARƔ. Once the cells
have committed, adipogenesis commences and the cells begin to take up lipid.
The lipid-loaded cells are then considered to be mature adipocytes (70).
Endothelial progenitor cells (EPCs) have been shown to integrate into
existing vasculature and improve blood flow. These cells are recruited to sites of
vascular injury to help repair damage. Levels of these cells can be influenced not
only by obesity, but by several environmental factors such as exposure to air
pollution and components of cigarette smoke (68, 69, 71, 72). Reduced EPC
count has been correlated with increased risk of cardiovascular disease and
17

decreased ability to create functional vascular networks, thus these cells are of
particular interest to our group (73-78). The cells were first characterized by a
group at Tuft’s University lead by Takayuki Asahara. In 1997, this work was
published in Science and is now considered to be a seminal paper in the field of
vascular biology. The paper asserts that progenitor cells in blood have the
capacity to improve vascularity in ischemic tissues. These cells have been shown
to differentiate into mature endothelial cells in vivo and integrate into damaged
vascular beds or organize to form new capillary networks. CD34+ cells isolated
from human blood and Flk1+ cells isolated from mouse blood were transplanted
into a mouse or rabbit model of hindlimb ischemia 2 days after removal of the
femoral artery. CD34+ cells integrated into damaged capillary networks and
generated new capillary beds in the ischemic limb within 6 weeks of
transplantation. Flk+ cells were also observed in capillaries and small arteries in
the ischemic limb 4 weeks after transplantation. This integration was not
observed in non-ischemic limbs suggesting EPCs promote vascularity in
ischemic tissue. All of the transplanted cells which engrafted into the ischemic
tissues stained positive for CD31, a marker of mature endothelial cells,
corroborating the group’s hypothesis that EPCs differentiate into mature
endothelium in vivo (79).
Since the initial identification of EPCs, several studies have confirmed that
progenitors similar to Asahara’s, CD34+ or Flk+ cells have regenerative capacity
(68, 69, 71, 80-82). Taken together, it can be concluded that EPCs function to
repair damaged vasculature in order to maintain adequate tissue oxygenation,
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preventing further ischemia-induced cell death and fibrosis (75). Interestingly, the
term “EPC” is a general one describing a variety of cell types that have been
shown to promote angiogenesis or vessel repair (68, 69, 71, 75, 80, 82). We
chose to investigate the role of Flk1 and Sca-1 positive cells which have been
affirmed as an EPC population in mice (68, 69, 71). We hypothesize that both
adipocyte and endothelial progenitor cell populations are crucial for the favorable
remodeling of adipose tissue during obesity, ameliorating hypoxia and promoting
adipocyte turnover.
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Project Objective
Obesity is one of most rapidly growing health crises in the United States
and its prevalence is on the rise worldwide. Increased risk for the development of
Type 2 diabetes, insulin resistance, and cardiovascular disease are just three of
the most devastating complications associated with obesity. Achieving a more
complete understanding of the mechanisms that regulate adiposity could
facilitate the development of new treatment strategies for controlling obesity and
the associated cardiovascular complications. Environmental and genetic factors
can contribute to adipose tissue distribution and increased adiposity, but studies
investigating a form of “healthy,” morbid obesity could provide insight into the
mechanism by which lipid storage can be stimulated under conditions of nutrient
excess while maintaining metabolic homeostasis, preventing diet-induced insulin
resistance. Small adipocytes, lack of adipose tissue inflammation, and adequate
adipose tissue oxygenation are hallmarks of this favorable remodeling process,
which is in stark contrast to typical unfavorable, diet-induced pathological
adipose tissue remodeling, characterized by large adipocytes, adipose tissue
hypoxia, chronic inflammation, and systemic insulin resistance. We are interested
in determining why the pathological form of adipose remodeling is generally the
default for lipid storage. We hypothesize that obesity impairs stem cellmediated adipose tissue remodeling.
Although obesity is a disease relating to metabolism in general, little is
known about the metabolic changes occurring in adipose tissue during the
course of obesity. This is important because of the likely metabolic
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underpinnings of pathological and metabolically favorable adipose tissue
remodeling. Thus, in Chapter 2, we examine the metabolic changes that occur in
the visceral adipose tissue with obesity. Importantly, this involves obesity model
characterization and in-depth assessment of the metabolic pathways that change
in pathological forms of adipose remodeling. To determine how obesity regulates
stem cell populations in adipose tissue, we assessed changes in stromal adipose
stem cell populations in visceral and subcutaneous adipose tissue of adult
C57BL/6J mice fed a low- or high-fat diet (Chapter 2). To completely address
Aim 1, we also measured proliferation of adipose tissue stem cells in obese and
lean mice, and examined how reversion to a low-fat diet affects adipose tissue
stromal cell population in mice. The results from these studies will be discussed
in Chapter 3. Our data suggest that conditions of obesity result in a significant
decline in the availability of endothelial progenitor cells in the adipose tissue. To
delineate the contribution of stem cells to adipose tissue remodeling, isolated
endothelial progenitor cells were also transplanted directly into the visceral
adipose tissue to determine if supplementation of these vascular progenitors was
sufficient to promote a positive form of adipose tissue remodeling (Chapter 4,
Aim 2). Since we also saw a decrease in endothelial nitric oxide synthase with
increased adiposity (54), bone marrow cells were isolated from mice
overexpressing endothelial nitric oxide synthase and transplanted into wild-type
mice which were then placed on high-fat diet for several weeks. The hypothesis
being that simultaneously increasing endothelial nitric oxide synthase and stem
cells availability in the adipose tissue may be sufficient to promote physiological
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adipose tissue remodeling. Changes in body weight, insulin sensitivity,
inflammation, adipocyte hypertrophy, were measured. The results of these
studies will help in assessing the impact of obesity and inflammation on the
competency of adipose tissue stem cells and in evaluating whether cell therapy
could improve metabolic dysregulation associated with obesity.

22

CHAPTER 2
METABOLIC REMODELING OF WHITE ADIPOSE TISSUE IN OBESITY

Introduction
The increasing prevalence of obesity is a principal health concern
worldwide. In 2008, approximately 1.5 billion adults aged 20 years or older were
overweight, and 10% were obese (83). In the US, more than one-third of the
adult population is currently obese (BMI >30), and 68% have a BMI>25 (84). By
the year 2025, these numbers are expected to increase by more than 50% (85).
These statistics are a cause for alarm. Obesity is a powerful predictor of insulin
resistance (86) and a major risk factor for several common medical conditions,
such as type 2 diabetes (T2D), cardiovascular disease, non-alcoholic fatty liver
and gallstones, Alzheimer’s disease, and cancers such as breast, colon,
endometrial, and esophageal cancer (87).
While lack of exercise is an undeniable risk factor for weight gain (87-89),
excessive caloric intake appears to be one of the key factors fueling the obesity
epidemic. In the past three decades, the average consumption of calories in the
US has increased by at least 200 kcal/d per person, which could be partly
attributable to an increase in the intake of energy-dense foods (90-93). Such
poor dietary habits negatively affect metabolic homeostasis, which could not only
promote obesity, but hasten the development of obesity-related co-morbidities as
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well.

Despite the simplicity of the apparent remedy (i.e., decreasing caloric

intake), treatment of obesity remains a challenging crisis facing the health care
system. The efficacy of losing weight via caloric restriction is limited by multiple
challenges. These include an evolutionarily engendered guard against starvation
and low fat mass (85, 94) and a propensity to increase caloric efficiency during
dieting (95, 96). While drugs with anorectic and anti-obesogenic properties are in
clinical use, many of these show marginal long-term efficacy or have
unacceptable or overtly dangerous side effects.

Thus, recent strategies to

modulate obesity have begun to target tissues that naturally regulate energy
metabolism (85).
Increasing energy expenditure by modulating adipose tissue activity could
be an attractive target for therapy. Because adult humans maintain small depots
of brown fat capable of burning significant amounts of calorific energy (97-100),
multiple studies have focused on the physiological and molecular mechanisms
regulating the thermogenic capacity of adipose tissue.

These studies have

shown that adaptive thermogenesis in brown fat can be a powerful regulator of
systemic energy metabolism. However, the relatively small amount of brown
adipose (<0.4% of body weight) compared with white adipose tissue (WAT;
which can comprise >40% of the body weight of an obese human) suggests that
WAT may be a more tangible target. Interestingly, white adipose depots, which
typically function to esterify free fatty acids and store excess lipids, have the
capacity to develop into brown adipose-like tissue capable of modulating
systemic metabolism and preventing obesity and insulin resistance (101).
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While the phenomenon of adipose tissue “browning” is an active area of
research, there is also considerable interest in understanding the metabolic
changes that occur in WAT with obesity. It is becoming increasingly clear that
conditions of nutrient excess promote “whitening” of adipose tissue characterized
by a decrease in mitochondrial abundance (47-49).

Hence, while promoting

browning is one way to positively modulate metabolism, decreasing adipose
tissue whitening could be another strategy to prevent dysregulation of systemic
metabolism during obesity. Indeed, the beneficial metabolic changes induced by
drugs such as rosiglitazone and pioglitazone have been suggested to be due, in
part, to their ability to prevent loss of mitochondria or increase mitochondrial
function in WAT (49, 102). Nevertheless, mitochondrial changes in WAT during
the development of obesity have not been thoroughly examined, and it remains
unclear how changes in adipocyte metabolism affect adipocyte hypertrophy and
metabolic homeostasis.
In this study, we examined WAT-specific changes in metabolism in a
mouse model of diet-induced obesity.

Our data indicate extensive metabolic

remodeling of WAT that precedes both the infiltration of inflammatory cells and
overt decreases in mitochondrial abundance.

This renovation of adipocyte

metabolism involved changes in glucose and lipid pathways that appear to favor
fat storage and prevent excessive lipid oxidation. The metabolite profile also
yields evidence of osmotic stress and adipocyte inflammation. Restructuring of
intermediary metabolism was accompanied by biochemical and ultrastructural
evidence of autophagy, which may promote degradation of mitochondria. These
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findings have important implications for understanding the metabolic effects of
obesity on adipose tissue metabolism and suggest that targeting metabolic
pathways that contribute to adipose tissue whitening or hypertrophy could form
the basis for novel therapies to combat metabolic disease.

Experimental procedures
Animal studies: All procedures were approved by the University of Louisville
Institutional Animal Care and Use Committee. C57BL/6J (wild-type; WT) mice
were purchased from The Jackson Laboratory (Bar Harbor, ME). At 8 weeks of
age, male mice were placed on either a 10% low fat diet (LFD; Research Diets,
Inc., #D12450B) or a 60% high fat diet (HFD; Research Diets Inc., #D12492) for
6 or 12 weeks. Water and diet were provided ad libitum. Body weights were
recorded weekly.
Metabolic phenotyping: Body composition was measured by dual-energy X-ray
absorptiometry using a mouse densitometer (PIXImus2; Lunar, Madison, WI),
and whole body energy expenditure; respiratory exchange ratio; food
consumption; and locomotion, ambulatory and fine movements were measured
using a physiological/metabolic cage system (TSE PhenoMaster System, Bad
Homberg, Germany) (103).

Glucose and insulin tolerance tests and plasma

levels of insulin were measured exactly as described in Sansbury et al (103).
Adipocyte size measurements: Adipose tissue was excised at the time of
euthanasia, and wet weight was recorded. All adipose tissue was either snap26

frozen at –80°C or fixed in 10% formalin, paraffin embedded, and sectioned. The
sections were stained in hematoxylin and eosin. Adipocyte cross-sectional area
and distribution was determined using Nikon Elements software. Adipose tissue
sections were assessed for crown-like structures as described previously (104).
Adipose tissue metabolite profiling: WAT from the epididymal fat pads of mice fed
LFD or HFD for 6 weeks were used for these analyses. Prior to tissue collection,
the mice were fasted for 16 h. After euthanasia, the adipose tissue was removed
and immediately snap-frozen in liquid nitrogen. Relative metabolite abundance
was then measured by GC/MS or LC/MS as described before (103, 105).
Metabolites with missing values were imputed by replacing missing values with
half of the minimum positive value in the original data.

After a generalized

logarithm transformation, the data were autoscaled, i.e., mean-centered and
divided by the standard deviation of each variable. This step was performed to
transform the intensity values so that the distribution was more Gaussian.
Univariate (e.g., volcano plots), multivariate (e.g., PLS-DA), and cluster (heatmap
and dendogram) analyses were then performed. Most analyses were performed
using Metaboanalyst 2.0 software (http://www.metaboanalyst.ca/) (106); z-score
plots were constructed in GraphPad 5.0 software.
Adipose tissue bioenergetic measurements: The oxygen consumption rate
(OCR) of intact WAT explants was measured using a Seahorse XF24 analyzer
(Seahorse Bioscience, Billerica, MA) as described previously (103). At least two
replicates from each animal were used for the assay. After baseline
measurements, the maximal OCR was measured by exposing the explants to
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FCCP (10 µM). The non-mitochondrial OCR was measured following injection of
antimycin A (25 μM) and rotenone (5 μM).
Citrate synthase activity assay: Citrate synthase assay was performed in 100 mM
Tris-HCl, pH 8.0, containing 1 mM EDTA, 1 mM 5', 5'-dithiobis 2-nitrobenzoic
acid, 10 mM acetyl-CoA. The reaction was initiated by addition of 10 mM
oxaloacetate. Cuvettes were warmed to 37°C, and upon addition of 10 μg of
protein from WAT lysates, absorbance at 420 nm was measured for 10 min.
Activity is expressed as nmoles/min/μg protein.
Expression analyses: For quantitative RT-PCR, RNA was extracted from tissues
using the RNeasy lipid tissue kit (Qiagen), followed by cDNA synthesis. Realtime PCR amplification was performed with SYBR Green qPCR Master Mix (SA
Biosciences) using a 7900HT Fast Real-Time PCR System (Applied Biosystems)
and commercially available primers for Il1, Tnfa, Il6, Arg1, Il10, Ym1, Hif1a,
Emr1, Pgc1a, Cytc, Sirt1, Sirt3, Pdk4, Cpt1a, Cpt1b, Cox7a1, Hprt, and Idh3a
(SA Biosciences). Relative expression was determined by the 2 −ΔΔCT method. M1
macrophages in WAT were measured by flow cytometry as described previously
(104).
For measuring protein abundance, WAT homogenates were prepared as
described in Horrillo et al. (107). Equal amounts of protein were separated by
SDS-PAGE, electroblotted to PVDF membranes, and probed using primary
antibodies according to the manufacturers’ protocol. The following antibodies
were used: ALDH2 (Abcam), Sirt3 (Cell Signaling), MitoProfile® Total OXPHOS
Rodent WB Antibody Cocktail (Mitosciences), COX4I1 (Cell Signaling), GAPDH
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(Cell Signaling), Parkin (Abcam), Pink1 (Cell Signaling), p62 (Cell Signaling),
LC3 (Cell Signaling), protein-ubiquitin (Cell Signaling) and α-tubulin (Cell
Signaling). Fluorescent or HRP-linked secondary antibodies (Invitrogen) were
used to detect and visualize the protein bands with a Typhoon 9400 variable
mode imager (GE Healthcare). Band intensity was quantified using Image Quant
TL® software.
Relative mitochondrial DNA (mtDNA) measurements: Mitochondrial abundance
in adipose tissue was estimated by measuring mtDNA abundance, relative to
nuclear DNA (nDNA) (108). Total DNA was isolated from WAT using a QIAamp
DNA Mini Kit (Qiagen). A 25 mg aliquot of the tissue was homogenized followed
by overnight digestion in Proteinase K at 55°C.

Following isolation, relative

amounts of mtDNA and nDNA were compared using quantitative real-time PCR
using 2 ng of the isolated DNA. Primers for cytochrome b (mtDNA) and β-actin
(nDNA)

were

used;

the

sequences

are:

cytochrome

b,

5’-

and

TTGGGTTGTTTGATCCTGTTTCG-3’
β

CTTCGCTTTCCACTTCATCTTACC-3’;

5’5’-

-actin,

CAGGATGCCTCTCTTGCTCT-3’ and 5’-CGTCTTCCCCTCCATCGT-3’.

Electron microscopy: Adipose tissues were fixed with 3% glutaraldehyde in 0.1 M
sodium phosphate buffer (pH 7.4) for 4 h at room temperature (25°C). The
tissues

were

then

post-fixed

with

1%

osmium

tetroxide

for

1

h,

dehydrated, embedded in Embed-812 plastic (Electron Microscopy Sciences).
Ultrathin sections were stained with uranyl acetate and Reynolds lead citrate,
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and electron micrographs were taken using a Philips CM10 transmission electron
microscope operating at 80 kV.
Statistical analyses: Data are mean ± SEM. Unpaired Student’s t test was used
for direct comparisons. Statistical analyses for metabolomic datasets were
performed using Metaboanalyst 2.0 software. A P value <0.05 was considered
significant.

Results
High fat diet increases adiposity and alters systemic metabolism: Wild-type
C57BL/6J mice were placed on a LFD or HFD for 6 weeks. Significant weight
gain occurred as early as 1 week on HFD, and the change in total body mass
was nearly 10 g by 6 weeks on the diet (Figure 1A). Food and water intake were
not significantly different between groups (Figure 1B&C). Dexascan analysis
showed a 2-fold increase in % fat mass and a concomitant decrease in % lean
mass in HF-fed mice (Figure 1D&E). These results are typical of this commonly
utilized model of diet-induced obesity (103, 109).
To determine how diet affects systemic metabolism, mice fed either LFD
or HFD for 6 weeks were placed in metabolic chambers, and their oxygen
consumption (VO2), carbon dioxide production (VCO2), and physical activity were
measured. As shown in Figure 1F and G, average VO2 and VCO2 values
decreased in HF-fed mice compared with mice fed a LFD. The respiratory
exchange ratio (RER) was also decreased in HFD mice versus mice fed LFD
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(Figure 1H).

Physical activity, measured by total beam breaks (Figure 1I),

ambulatory counts (Figure 1J), and fine movements (Figure 1K), were not
significantly different between groups, although the group fed a HFD appeared to
show a trend toward decreased activity. Consistent with our previous results
(103), mice fed a HFD also demonstrated worsened glucose and insulin
tolerance (Figure 2) as well as a significant increase in plasma insulin levels (WT
LFD, 151±71 pg/ml vs. WT HFD, 2690±593 pg/ml, n = 3 per group, p<0.05).

31

32

Figure 1: Effects of high fat diet on weight gain, adiposity and systemic
metabolism. Male WT C57BL/6J mice were fed a low fat diet (LFD, 10% kcal
fat) or high fat diet (HFD, 60% kcal fat) for 6 weeks and the following
measurements were recorded: (A) mouse weights during 6 weeks of feeding, n =
20 per group; (B) food intake, n = 7 per group; (C) water intake, n = 7 per group;
(D) representative DexaScan images; (E) percentages of lean mass and body
fat, n = 10 per group; and (F) average oxygen consumption (VO2); (G) average
carbon dioxide production (VCO2); (H) respiratory exchange ratio (RER); (I) total
activity level; (J) ambulatory counts; and (K) fine movements. n = 7 per group;
*p<0.05 vs. LFD.
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Figure 2: Glucose and insulin tolerance in mice fed low fat or high fat diets.
After 6 weeks of a low fat (LFD) or high fat diet (HFD), glucose tolerance and
insulin sensitivity were examined: (A) Glucose tolerance test (GTT); (B) GTT
area under the curve (AUC); (C) insulin tolerance test (ITT) shown as % of
baseline; and (D) ITT AUC. n = 7 per group; *p<0.05, **p<0.01 vs. LFD.
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Robust macrophage infiltration does not occur with 6 weeks of HFD: To examine
the effects of HFD on macrophage infiltration, we placed mice on LFD or HFD for
6 or 12 weeks and measured adipocyte size, crown-like structures that are
indicative of macrophage infiltration, as well as the expression of inflammatory
genes. As shown in Figure 3A–C, mice fed a HFD for 6 and 12 weeks showed a
3- to 4-fold increase in adipocyte size when compared with LFD controls. While
sections of WAT derived from mice fed a HFD for 12 weeks showed obvious
increases in crown-like structures, WAT from mice fed HFD for 6 weeks showed
minimal increases in such structures. These observations suggest that with 6
weeks of HFD, there is minimal macrophage accumulation.

Indeed, the

expression of Emr1—a marker of macrophages—as well as that of other
inflammatory genes was not changed with 6 weeks of HFD (Figure 3D).
Moreover, the abundance of M1 macrophages in adipose tissue stromal vascular
fractions

was

not

different

between

mice

fed

different

diets

(F4/80+/CD11c+/CD301- cells as %F4/80+ cells: LFD 37.4±3.5; HFD, 45.9±1.8; n
= 9–10 per group, p>0.05.). Most likely, the modest, insignificant increase in
Tnfa is due to adipocytes, which have been shown to be capable of producing
TNF-α (110, 111). In addition, no increase in plasma levels of inflammatory
mediators such as IL-6 were identified at 6 weeks of HFD (IL-6 (pg/ml): LFD,
23.6±7.5; HFD, 18.8±4.2). Collectively, these data show that adipocyte size was
increased after 6 weeks of HFD, without significant changes in infiltrating
inflammatory cells.
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Figure 3: Effect of HFD on adipose tissue expansion and inflammation.
Morphological and molecular changes in adipose tissues: (A) Representative
hematoxylin and eosin stains of epididymal adipose tissue from mice fed a LFD
or HFD for 6 or 12 weeks; inset shows a crown like structure (CLS) in the 12
week HFD group; (B) average area of adipocytes; (C) adipocyte size distribution;
and (D) qRT-PCR analyses of markers of inflammation in adipose tissues from
mice fed a LFD or HFD for 6 weeks. n = 4-5 per group; *p<0.05 vs. indicated
groups.
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Obesity alters the metabolite profile of adipose tissue: To examine the effect of
obesity on adipose tissue metabolism, epididymal WAT from mice fed a LFD or
HFD for 6 weeks was subjected to unbiased metabolomic analysis. The relative
concentration of adipose metabolites was measured by mass spectrometry and
queried against the Metabolon reference library. It is important to note that the
composition of adipose tissue derived from mice fed LFD differed from mice fed
HFD. In comparison with the LFD group, the protein yield per mg wet weight was
43% lower in the adipose tissue of the HFD group (µg protein/mg wet weight: 6
wk LFD, 10.86±1.70; 6 wk HFD, 6.21±1.28; n = 10–12 per group). Hence, for
metabolomic analyses, we corrected for this difference in protein content. Partial
least squares-discriminant analysis (PLS-DA) with the corrected data showed
that the LFD samples separate clearly from HFD samples (Figure 4A), and
cluster analysis showed that the abundance several metabolites was associated
with diet (Figure 4B). Of the 191 metabolites measured, 49 were found to be
significantly different (p<0.05) in the WAT of mice fed a HFD compared with the
adipose tissue from mice fed LFD. Volcano plot analysis, using data corrected
for protein content, showed significantly higher levels of 34 metabolites and
significantly lower levels of 15 metabolites in adipose tissue of HF-fed mice
compared with those fed LFD (Figure 4C and Table 1). Volcano plot analysis
based on uncorrected, raw data showed a large skew towards decreased
abundance of most metabolites (Figure 4C, inset). To visualize the data in the
biological context of metabolic pathways, metabolites that were statistically
different in each group were analyzed using the MetPA tool of Metaboanalyst 2.0

39

software. The pathways were calculated as the sum of the importance measures
of the matched metabolites normalized by the sum of the importance measures
of all metabolites in each pathway (105, 112).

As shown in Figure 4D, the

highest pathway impact values were related to linoleic acid metabolism and Phe,
Tyr, and Trp metabolism. Branched chain amino acids (BCAA) i.e., Val, Leu, and
Ile, and pathways related with taurine metabolism; glycerolipid metabolism; Ala,
Asp and Glu metabolism; carbohydrate metabolism; and pyrimidine metabolism
also showed relatively high pathway impact and significance values.
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Figure 4: Metabolomic analyses of adipose tissue. Metabolomic analyses of
epididymal adipose tissue metabolites from WT mice fed a LFD or HFD for 6
weeks: (A) Multivariate analysis: partial least squares-discriminant analysis (PLSDA); inset shows PLS-DA analysis from the uncorrected dataset (B) Hierarchial
clustering: Heatmap and dendogram; (C) Univariate analysis: Volcano plot of
metabolites. Those metabolites that were significantly higher in abundance are in
the quadrant shaded red and those that were significantly lower are shaded
green (p<0.05, t-test). The identity of these metabolites is found in Table 1. The
inset shows volcano plot analysis using data that were not corrected for protein
content; (D) Metabolites found to be significantly different were subjected to
pathway impact analysis using Metaboanalyst MetPA and the Mus musculus
pathway library. Fisher’s exact test was used for overrepresentation analysis,
and relative betweenness centrality was used for pathway topology analysis. n =
14 animals: 7 WT LFD and 7 WT HFD.
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Table 1

Fold
change

p value

FDR

*stearoyl sphingomyelin

2.8

0.000542

0.010414

*glycerophosphoethanolamine

2.7

7.09E-08

1.36E-05

*succinate

2.34

0.000139

0.006385

inosine 5'-monophosphate (IMP)

2.27

0.016131

0.088492

uridine monophosphate (5' or 3')

2.26

0.009442

0.064744

dihomo-linoleate (20:2n6)

2.03

0.011868

0.071209

pelargonate (9:0)

2.02

0.030984

0.14203

*cytidine 5'-monophosphate (5'-CMP)

1.95

0.000214

0.006839

*Isobar: fructose 1,6-diphosphate, glucose 1,6diphosphate, myo-inositol 1,4 or 1,3-diphosphate

1.87

0.000166

0.006385

maltose

1.86

0.03107

0.14203

docosapentaenoate (n3 DPA; 22:5n3)

1.83

0.033432

0.14928

*glutamate

1.81

0.000111

0.006385

glucose

1.8

0.005764

0.046111

azelate (nonanedioate)

1.75

0.001215

0.01795

dihomo-linolenate (20:3n3 or n6)

1.75

0.006864

0.052713

stearate (18:0)

1.74

0.003972

0.038131

arachidonate (20:4n6)

1.68

0.001536

0.021059

deoxycarnitine

1.64

0.000539

0.010414

glycerophosphorylcholine (GPC)

1.64

0.005243

0.045087

hypotaurine

1.62

0.024921

0.12592

12-HETE

1.61

0.036945

0.16121

acetylcarnitine

1.54

0.000362

0.008923

margarate (17:0)

1.51

0.046138

0.18455

aspartate

1.47

0.003862

0.038131

creatine

1.46

0.000666

0.01162

malate

1.45

0.008981

0.063867

linoleate (18:2n6)

1.42

0.026561

0.13076

palmitoyl ethanolamide

1.38

0.02444

0.12592

Metabolite
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propionylcarnitine

1.37

0.048868

0.18902

taurine

1.33

0.001968

0.024159

glutamine

1.32

0.000372

0.008923

choline phosphate

1.32

0.011199

0.06936

citrulline

1.29

0.002367

0.025244

cholesterol

1.28

0.002251

0.025244

*leucine

0.79

0.005401

0.045087

*tyrosine

0.78

0.042828

0.18273

pantothenate

0.73

0.049223

0.18902

mead acid (20:3n9)

0.66

0.028737

0.13794

phenylalanine

0.62

0.011086

0.06936

valine

0.6

0.00483

0.044159

3-dehydrocarnitine

0.58

0.013332

0.077568

1,5-anhydroglucitol (1,5-AG)

0.56

0.010344

0.068482

glucose-6-phosphate (G6P)

0.51

0.045306

0.18455

histamine

0.46

0.017878

0.095349

ergothioneine

0.45

0.000163

0.006385

*N-acetylmethionine

0.35

0.002013

0.024159

*mannose-6-phosphate

0.33

0.013998

0.079048

*glycerate

0.07

0.008323

0.061462

*glycylleucine

0.05

0.000986

0.015774
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Table 1. List of adipose tissue metabolites that changed significantly in
high fat-fed mice. Wild-type (WT) mice were fed a low fat or high fat diet (LFD
or HFD, respectively) for 6 weeks. Epididymal adipose tissue was then subjected
to LC or GC mass spectrometric analysis. Raw spectral values from WAT of HFfed mice were corrected based on the mean difference in protein content (per mg
wet weight) compared with WAT from LF-fed mice. Adipose tissue metabolites in
HF-fed mice that were at least 25% changed in abundance and significantly
different (p<0.05) compared with LF-fed mice are shown. n = 7 mice per group;
*indicates those metabolites that were significant even when ±2 SEM were
applied in protein correction.
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To delineate changes in metabolites further, metabolites were categorized based
on superfamily class, and z-score plots were constructed. As shown in Figure 5,
the abundance of multiple lipid superfamily members, including those involved in
glycerolipid metabolism and linoleic acid metabolism was higher.

Several

carnitine derivatives, with the sole exception of 3-dehydrocarnitine, were higher
in abundance as well. In the amino acid superfamily, the levels of non-essential
amino acids Glu, Gln and Asp were elevated, and those of essential amino acids
Phe, Leu and Val were lower.

Notably, the organic osmolytes—taurine,

hypotaurine and creatine—were more abundant. In the HFD group, levels of the
Krebs cycle intermediate succinate were higher; levels of malate were higher as
well, although pantothenate, a precursor to Coenzyme A (CoA), was less
abundant. While both glucose and maltose levels were higher, phosphorylated
sugars were diminished. Plasma 1,5-anhydroglucitol (1,5-AG), which is present
in most organs and tissues and has been shown to decrease with loss of
glycemic control (113, 114), was diminished in abundance, which is in agreement
with insulin resistance in skeletal muscle and liver occurring at 6 weeks of HFD
(109). Interestingly, the pyrimidine monophosphates cytidine-5’-monophosphate
(CMP) and uridine monophosphate (UMP), as well as the purine inosine-5’monophosphate, were elevated in WAT from HF-fed mice.

A graphical

illustration of these changes, placed into context of known pathways of
intermediary metabolism, is shown in Figure 6.
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Figure 5: Z-score plot analysis of metabolite changes in adipose tissue
from high fat fed mice. Mice were fed a LFD or HFD for 6 weeks. Data are
shown as standard deviations from the mean of LFD. Z-scores of some
metabolites were not plotted due to lack of detectable signal in either LFD or
HFD groups, e.g., glycylleucine, glycerate. Each point represents one metabolite
in one sample. n = 7 per group.
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Figure 6: Illustration of metabolite changes in adipose tissues of obese
mice. Metabolic changes in adipose tissue that occur with HFD are shown in the
context of known metabolic pathways. In red are those metabolites that
increased, and in green (and underlined) are those metabolites that decreased,
in obese mice. 12-HETE, 12-Hydroxyeicosatetraenoic acid; BCAAs, branched
chain amino acids; CoA, coenzyme A; CMP, cytidine 5’-monophosphate; DHAP,
dihydroxyacetone phosphate; FAs, fatty acids; F6P, fructose-6-phosphate; F1,6-P2, fructose-1,6-bisphosphate; G3P, glycerol-3-phosphate; G6P, glucose-6phosphate; GA3P, glyceraldehyde-3-phosphate; GPC, glyerophosphorylcholine;
GPE, glycerophosphoethanolamine; IMP, inosine 5’-monophosphate; UMP,
uridine monophosphate (5’ or 3’). *isobaric entity: Metabolite identity is unclear
from the data and could be either F-1,6-P2, glucose-1,6-diphosphate, or myoinositol 1,4 or 1,3 diphosphate; #denotes organic osmolytes that changed in
abundance.
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Effect of obesity on oxygen consumption and mitochondrial remodeling in WAT:
The changes in energy metabolism found in our metabolomic analyses
suggested that HFD might have altered adipose tissue bioenergetics.
Importantly, these changes occurred in the absence of inflammatory cell
infiltration (see Figure 3), which could otherwise confound adipocyte-specific
changes in metabolism. To determine how obesity affects mitochondrial function,
WAT explants from mice fed a LFD or HFD were subjected to extracellular flux
analysis. As shown in Figure 7A and B, the apparent basal mitochondrial oxygen
consumption rate of adipose tissue derived from mice fed a LFD was >2-fold
higher when compared with adipose explants derived from HF-fed mice (p<0.05);
however, after correction for protein content, there was no difference in
mitochondrial oxygen consumption. Nevertheless, explants derived from mice
fed a HFD responded more strongly to FCCP (Figure 7C).

Although citrate

synthase activity was lower by more than 50% in WAT derived from these mice
(Figure 7D), relative abundance of mtDNA, as assessed by qPCR of mtDNA
normalized to nDNA, was not affected with 6 weeks of HFD (Figure 7E).
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Figure 7: Obesity-related energetic changes in white adipose tissue.
Metabolic analysis of adipose tissue from mice fed a LFD or HFD for 6 weeks:
(A) Extracellular flux analysis: After three basal oxygen consumption rate (OCR)
measurements, FCCP (10 µM) was injected, followed by injection of antimycin A
(AA, 25 μM) and rotenone (Rot, 5 μM). Gray circles indicate values from HF-fed
mice that were corrected based on differences in protein content compared with
LF-fed mice. For clarity, error bars were omitted from the HFD corrected group.
Dotted lines indicate ±2SEM from corrected values. (B) Detailed changes in
basal, maximal (Max.), non-mitochondrial (N.M.), basal mitochondrial (Mitobasal),
and maximum mitochondrial (Mitomax) rates of oxygen consumption; (C) FCCP
response: the FCCP response in each explant was calculated using the
equation: (OCRMAX/OCRBASAL) × 100; n = 10 mice per group; (D) citrate synthase
activity, n = 3-6 mice per group; (E) Relative mtDNA content, n = 6 per group.
*p<0.05 vs. LFD group.
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The observed changes in metabolite profile, increased mitochondrial
responsiveness to FCCP, and diminished citrate synthase activity suggested that
HFD might affect the expression of genes associated with metabolic activity.
Indeed, the expression of Cox7a1, a subunit in the electron transport chain, was
more than 2-fold higher in adipose tissue from mice fed a HFD, whereas the
expression of Pgc1a, Sirt3, and Pdk4 expression was diminished (Figure 8A),
indicating mitochondrial remodeling despite preserved basal mitochondrial
activity.
To further understand how WAT mitochondria change with obesity, we
assessed the relative abundance of several mitochondrial complex proteins as
well as mitochondrial matrix proteins. Although no changes in mitochondrial
protein abundance were observed at 6 weeks of HFD, the protein levels of
NDUFB8, SDHB, and COX4I1—subunits of complexes I, II, and IV,
respectively—were diminished significantly by 12 weeks of HFD (Figure 8B–E).
The levels of the matrix proteins – ALDH2 and Sirt3 – showed similar trends, with
ALDH2 being significantly lower after 12 weeks of HFD.

54

55

Figure 8: Obesity-related changes in mitochondrial protein abundance in
white adipose tissue. Analysis of gene expression and protein abundance
adipose tissue from mice fed a LFD or HFD for 6 or 12 weeks: (A) Expression of
metabolic genes; (B) Representative Western blots of mitochondrial matrix
proteins and respiratory chain subunits; (C) Quantification of ALDH2; (D)
Quantification of Sirt3; (E) Quantification of respiratory subunit abundance. All
blots were normalized to ATP5A, which showed no change in abundance in any
group. n = 4 per group; *p<0.05 vs. 6 wk LFD, #p<0.05 vs 12 wk LFD.
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Assessment of adipose tissue ultrastructure: To determine subcellular changes
that occur in adipose tissue of nutrient-stressed mice, we examined adipocyte
ultrastructure using electron microscopy. As shown in Fig 9A, adipose tissue
from mice fed a LFD showed mitochondria with three distinct morphologies: a
round morphology of small size that was located near the nucleus (Figure 9A-i,ii);
a typical elongated shape up to ~0.7 μm in length located in small protrusions
along the adipocyte cell membrane (Figure 9A-iii); and long mitochondria (up to 5
μm and above), which were located in juxtaposition to the fat locule (Figure 9Aiv). In adipocytes derived from HF-fed mice, autophagosomes—defined by a
double-membrane and comprising cytoplasmic constituents—were found next to
mitochondria (Figure 9B-i), and large vacuoles of electron-dense material were
found adjacent to autophagosomes (Figure 9B-ii,iii). In addition, many
mitochondria in adipose tissues from HF-fed mice appeared to be undergoing
fission (Figure 9B-iv,v).
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Figure 9: Ultrastructure of white adipose tissues from lean and obese
mice. Representative transmission electron micrographs of epididymal adipose
tissues derived from mice fed a LFD or HFD for 6 weeks. (A) Ultrastructure of
mitochondria in adipose tissues from LF-fed mice: (i) micrograph of adipocytes in
areas close to the nucleus; (ii) higher magnification of panel i; (iii) a cytosolic
compartment containing a mitochondrion found protruding into the fat locule; and
(iv) an elongated mitochondrion in juxtaposition to the fat locule. (B)
Ultrastructure of adipose tissue derived from HF-fed mice: (i) An elongated
mitochondrion next to an autophagosome; (ii) an autophagosome in close
proximity to a vacuole containing electron-dense material; (iii) magnified image of
panel ii; (iv) protrusion of cytosolic compartment containing an atypical
mitochondrion; and (v) mitochondrion that appears to be undergoing fission.
Asterisks (*) indicate autophagosomes; small arrows indicate collagen;
mitochondria (M), nucleus (N), vacuole lipid droplet (LD).
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Effects of HFD on autophagy: Changes in citrate synthase and mitochondrial
proteins, along with the ultrastructural alterations found to occur in the adipose
tissue, suggest that HFD may promote mitochondrial remodeling and activate
mitophagy in WAT.

To examine this possibility, we measured markers of

mitophagy and autophagy in adipose tissues from mice fed a LFD or HFD for 6
weeks.

Levels of the E3 ubiquitin ligase Parkin, which has been shown to

accumulate in mitochondria destined for degradation (115), were 2.3-fold higher
with 6 weeks of HFD and nearly 2-fold higher after 12 weeks of HFD (Figure
10A,B).

Furthermore, the kinase Pink1—critical for identifying mitochondria

destined for autophagy (115)—was also nearly 40% higher in the HFD groups. In
combination with the presence of autophagosomes and mitochondrial alterations
observed by EM (Figure 9), this observation suggests that metabolic remodeling
of adipocytes in the expanding adipose organ may be related to autophagy. To
address this possibility, we measured changes in protein indicators of autophagy.
As shown in Figure 10C–H, levels of p62 and LC3-I were diminished significantly
and the LC3-II:LC3-I ratio was more than 2-fold higher in mice fed a HFD for 6
weeks in comparison with those placed on LFD.

However, there was no

significant difference in total protein abundance of protein-ubiquitin and LC3-II.
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Figure 10: Evidence for activation of mitophagy in WAT of obese mice.
Immunoblot analysis of markers of mitophagy and autophagy: (A) Western blots
of Parkin and Pink 1 in adipose tissues from mice fed a LFD or HFD for 6 weeks
(left panels) or 12 weeks (right panels); and (B) Quantification of Parkin and
Pink1 abundance from panel E. n = 4 per group; *p<0.05 vs. LFD. n = 4 per
group; (C) Representative Western blots of ubiquitinated proteins, p62, and LC3
in mice fed a LFD or HFD for 6 weeks. (D–H) Quantification of protein-ubiquitin
abundance, p62, LC3-I, LC3-II abundance, and LC3-II/LC3-I ratio. n = 10 per
group; *p<0.05 vs. LFD.
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Discussion
The results of this study demonstrate coordinated restructuring of adipose
tissue metabolism during adipocyte hypertrophy. Using metabolomics analysis,
we identified several HFD-induced changes in key metabolites involved in
energy, carbohydrate, nucleotide, lipid and amino acid metabolism. Importantly,
these changes were relatively independent of inflammatory cell infiltration, and
the data were corrected for adipocyte content; both of which help eliminate
confounding features related to tissue and adipocyte composition. Our analysis
showed an early decrease in citrate synthase activity that coincided with reduced
expression of Pgc1a, even though mitochondrial abundance was not affected.
Ultrastructural and immunological evidence suggested that whitening of the
adipose tissue, evident after 12 weeks of HFD, may also be related to
autophagy, which appears to occur early after adipocytes attain near maximum
size.

Taken together, these results reveal that conditions of nutrient excess

promote progressive metabolic remodeling, decreased capacity for mitochondrial
biogenesis, and potential activation of the autophagic program in WAT.
The major goal of this study was to understand how HFD affects adipose
tissue biology and metabolism.

This is important because key metabolic

changes that occur during adipocyte hypertrophy could be targets for anti-obesity
or insulin-sensitizing therapies. We found that 6 weeks of HF feeding led to a
profound increase in fat mass, which was accompanied by a decrease in
systemic VO2, VCO2 and RER, and insulin resistance. Although adipose tissue
inflammation is evident by the 10th-12th week of HFD (116, 117), we find no
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significant increase in inflammatory cell infiltration with 6 weeks of HFD (e.g.,
see Figure 3 and (109, 117)).

This lack of extensive tissue infiltration by

energetic inflammatory cells allowed us to examine HFD-induced changes
specific to the adipose tissue.
Moreover, in our metabolic measurements, we accounted for changes in
the composition of the adipocytes themselves. Because white adipocytes expand
by storing triglycerides in the central lipid droplet, an equivalent tissue mass of
WAT from a HF-fed mouse comprises fewer cells (and more triglyceride) than
adipose tissue from a LF-fed mouse. Thus, normalization of metabolite levels by
wet weight alone could lead to erroneous conclusions. An example of this is
shown in Figs. 4 and 6, where uncorrected values indicate that most metabolites
are decreased in WAT from HF-fed mice (Figure 4E, inset) and that
mitochondrial OCR is diminished in adipocytes from the obese mice (Figure
7A&B). Correcting for protein content in samples from HF-fed mice normalized
the distribution of metabolic changes and rectified the leftward skew caused by
decreased adipocyte content. Similarly, when values were normalized for protein
content (rather than mg wet weight), there was no difference in tissue oxygen
consumption between explants from LFD and HFD groups. This indicates that,
with 6 weeks of HFD, there was no change in basal mitochondrial oxygen
consumption per adipocyte.
Our metabolic profiling indicates that HFD affects several metabolic
pathways. In mice placed on HFD for 6 weeks, we found significant changes in
lipid, amino acid, energy, nucleotide, and carbohydrate metabolism. Higher levels
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of several fatty acids and lipid metabolites belonging to the linoleic acid
metabolism subfamily were observed in WAT from HF-fed mice. In this tissue,
there was also a higher abundance of arachidonic acid as well as metabolites
involved in arachidonic acid synthesis, including linolenic acid and dihomolinolenic acid, which indicates a coordinated upregulation of this pathway. WAT
from HF-fed mice also contained higher levels of the eicosanoid 12hydroxyeicosatetraenoic acid (12-HETE), which is formed from arachidonate by
12/15-lipoxygenase (12/15-LO). Interestingly, 12/15-LO is upregulated in white
adipocytes of both HF-fed C57BL/6J mice (118) as well as Zucker obese rats
(119). Thus, upregulation of 12/15-LO and increased production of its product
(12-HETE) are consistent features of hypertropic WAT. This may be particularly
significant in mediating adipose tissue dysfunction because two separate studies
have shown that genetic deletion of 12/15-LO prevents HFD-induced adipose
tissue inflammation and insulin resistance (120, 121).
The elevated levels of glycerophosphoethanolamine (GPEA) in WAT from
obese

mice

could

be

due

to

an

increase

in

the

breakdown

phosphatidylethanolamine or a decrease in its rate of hydrolysis.

of

Previous

studies have shown that GPEA is hydrolyzed by enzymes such as
glycerophosphodiester phosphodiesterase to form glycerol-3-phosphate (G3P)
(122), which is required for triglyceride synthesis and thus would likely be in high
demand in expanding adipocytes (123). Glycerophosphorylcholine (GPC), which
was elevated in WAT from HF-fed mice, could also be utilized to form G3P.
However, a major function of GPC in the cell is to act as an organic osmolyte
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(124), suggesting that there might be an increase in osmotic stress in
hypertrophic adipocytes. This view is supported by our observation that the levels
of several major osmolytes such as taurine, hypotaurine and creatine were
higher in WAT from obese mice. Changes in osmolality could trigger a form of
cell death called pyroptosis (125), which has been linked with inflammasome
activity (126). Interestingly, the NLRP3 inflammasome is activated by cholesterol
crystals, and, consistent with previous observations in hypertrophied adipocytes
(127, 128), our analyses also showed an elevation of cholesterol in adipose
tissue of obese mice. Collectively, these observations suggest an early increase
in key metabolic instigators that could contribute to osmotic stress and
inflammation in adipose tissue.
The HFD-induced increase in stearoyl sphingomyelin could further prime
adipocytes for inflammation and metabolic dysfunction. Sphingomyelin (SM;
d18:1/18:0)—which in humans is the only membrane phospholipid not derived
from glycerol—is a type of sphingolipid found in cell membranes that consists of
oleic acid attached to the C1 position and stearic acid attached to the C2
position. Genetic deletion of enzymes involved in sphingomyelin synthesis has
been shown to protect against diet-induced obesity and insulin resistance (129,
130), and the breakdown of sphingomyelin could yield significant amounts of
ceramide, which inhibits insulin signaling (131). Hence, the elevated levels of
sphingomyelin observed in our study could prime adipocytes to release
significant amounts of ceramide, which has been shown to be increased by
300% in both the plasma and the adipose tissue by HFD (132).
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Although

ceramide levels were not measured in our analyses, we did observe a decrease
in Pgc1a expression and a decrease in citrate synthase activity, both of which
can be regulated by ceramide (133, 134). However, further studies are required
to determine whether changes in mitochondrial biogenetic capacity and citrate
synthase activity are related to high levels of stearoyl sphingomyelin.
Our metabolomic data suggest significant changes in intermediary
metabolism related to energy expenditure and fat storage. We found that many
carnitine derivatives were increased in WAT from HF-fed mice. These include
acetylcarnitine,

proprionylcarnitine,

and

deoxycarnitine;

although

3-

dehydrocarnitine, an intermediate in carnitine degradation, was diminished.
These changes suggest the presence of a “flooded” pool of adipocyte
metabolites, which could be used for either energy provision, or, more likely, as a
temporary repository for substrates for fatty acid synthesis. In other tissues such
as the heart, acetylcarnitine functions as a buffer of the acetyl CoA pool, although
it could be used as an energetic substrate as well (135).

Similarly, the

propionylcarnitine could buffer the propionyl CoA pool (136). Thus, it appears
that in expanding adipocytes short-chain acylcarnitine pools could help buffer
excess carbon until it is assimilated into fatty acids for triglyceride storage.
The observations that tissue levels of BCAAs such as leucine and valine
were decreased, while propionylcarnitine and succinate levels were increased
with HFD, suggest an increase in BCAA catabolism.

Catabolism of BCAAs

results in the formation of both acetyl CoA and succinyl CoA, the latter can be
converted to succinate, which in our analysis was elevated in WAT from HF-fed
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mice.

Thus, it is likely that in hypertrophic adipocytes there is increased

utilization of BCAAs. In contrast to the decrease in BCAAs, we found that levels
of Gln and Glu were increased with HFD.

This increase may be particularly

important, given the multifaceted uses of glutamine, e.g., in anaplerotic
metabolism, as a nitrogen donor in anabolic processes, as well as a precursor for
glutathione synthesis (137, 138). In addition, Gln and Asp are required for
synthesis of several nucleotides such as IMP, UMP and CMP, all of which were
increased in these studies. Interestingly, adipose tissue is a major site of
glutamine synthesis, and its uptake can be regulated by changes in osmolality as
well as by insulin (139).
Although there is a clear relationship between amino acids, insulin
resistance and obesity in animal models and humans (140-142), the mechanistic
basis of this link is less clear. BCAA metabolism in adipose tissue modulates
plasma BCAA levels (143), and, interestingly, increasing circulating BCAAs in
mice by preventing BCAA catabolism prevents diet-induced obesity and insulin
resistance in mice (144), whereas feeding BCAAs to HF-fed rats increases
insulin resistance (142).

While further studies are required to test the full

significance of such metabolic changes in BCAAs and other amino acid
pathways, it is possible that changes in amino acid catabolism and downstream
metabolites have novel roles in adipose tissue biology such as the regulating lipid
storage and release. This possibility is supported by a recent report showing that
succinate, which can be derived from BCAA breakdown, inhibits lipolysis by
activating Gpr91 (a succinate receptor) (145).
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Metabolites related with glucose metabolism were also markedly affected
by HFD. We found a nearly 50% decrease in the abundance of 1,5-AG in WAT
samples from HF-fed mice. Plasma 1,5-AG is a validated marker of short-term
glycemic control and has been suggested to be in equilibrium in tissue and
plasma pools (113, 114). Hence, even though 6 weeks of HFD does not appear
to significantly affect fasting blood glucose levels (103), the decreased
abundance of 1,5-AG is consistent with systemic insulin resistance and poor
glycemic control (109).

With respect to glycolysis, glucose-6-phosphate was

decreased, and adipose tissue glucose was increased, suggesting that
hexokinase might be a major rate-limiting step in the provision of glucose
carbons required for triglyceride synthesis.

Further evidence of changes in

glucose metabolism is shown by diminished pdk4 expression, which regulates
pyruvate dehydrogenase activity. This decrease in pdk4 could potentially
promote glyceroneogenic formation of G3P (146) via cataplerosis (147).
Interestingly, while we observed no change in basal mitochondrial OCR
when corrected for protein content, WAT from HF-fed mice showed an increased
response to FCCP. We speculate that once metabolic restraint due to Δp is lifted
(by addition of uncoupler), the increased substrate available for oxidative
phosphorylation, e.g., succinate, malate, glutamate, short-chain acylcarnitines,
results in increased rates of oxygen consumption.

Also, in datasets corrected

for protein content, there was a trend toward an increased rate of nonmitochondrial oxygen consumption, which might suggest an increase in
adipocyte superoxide production due to cytosolic oxidase activity (115, 148).
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This possibility is consistent with previous studies showing an increase in
oxidative stress in adipose tissue of obese mice, which is predominantly caused
by an increase in NADPH oxidase and down-regulation of antioxidant enzymes
(149-153).
Further support for coordinated remodeling of mitochondrial and cytosolic
metabolism is provided by the observation that expression of Cox7a1 was
increased in the adipose tissue of obese mice. A similar increase in Cox7a1
gene has been shown in the WAT of fattening cattle (154), although the
implications of this increase are currently unclear. Cox7a1 is considered to be a
heart- and muscle-specific subunit of cytochrome oxidase, but it is also present in
brown adipose tissue; these tissues are highly metabolic organs capable of
utilizing large amounts of substrate. Thus, it is possible that the increase in
Cox7a1 may be an adaptive response to dissipate excessive energy in the
adipocyte. The decrease in citrate synthase activity, which provides additional
evidence for remodeling of mitochondrial metabolism during adipocyte
hypertrophy, is similar to that observed in db/db mice, where citrate synthase
activity is diminished remarkably with no change in mtDNA/nDNA (155).

Why

citrate synthase decreases in expanding adipocytes is currently unclear;
however, it could be an adaptation to prevent excessive influx of carbon into the
Krebs cycle, which would be consistent with the view that during obesity there is
an overall shift in metabolism from energy provision to lipid storage.
The notion that HFD remodels mitochondrial metabolism in adipocytes is
further supported by diminished mitochondrial biogenetic capacity and later
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decreases in electron transport chain protein abundance. With of 6 weeks of
HFD, mitochondrial abundance per se was not affected; however, we did find a
significant decrease in Pgc1a expression, which was followed by loss of
mitochondrial protein abundance after 12 weeks of HFD.

This relatively late

decrease in mitochondrial protein abundance may be due also to early changes
in mitochondrial metabolism that promote removal of mitochondria by autophagy.
Autophagy has been shown previously to be increased in adipocytes from obese
humans and mice (156-158). Consistent with those studies, our biochemical
results show an increase in the LC3-II/LC3-I ratio and a decrease in p62, the
combination of which would appear to be consistent with an increase in
autophagic flux (159, 160). Ultrastructural data showing autophagosomes and
vacuolated structures containing electron-dense material further suggest
changes in autophagy consistent with its activation. A limitation of this study,
however, is that autophagic flux was not directly measured, making it difficult to
ascribe

with

certainty directional changes to the autophagy pathway.

Nevertheless, an activation of autophagy in adipose tissue would be expected to
decrease the abundance of both LC3-I and p62 (161-164), which is consistent
with our results. Hence, our cumulative data are supported by evidence in the
literature and suggest that autophagy is activated by HFD. While we cannot
clearly distinguish whether mitochondria are removed by autophagy, the increase
in key proteins involved in mitophagy – Parkin and Pink1 (115, 165) – would be
consistent with a significant role of mitophagy in mediating mitochondrial
remodeling and turnover in the WAT of obese mice.
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In summary, in this study we identified key metabolic changes that occur
during WAT expansion. These coordinated changes occur before the infiltration
of inflammatory cells and include: loss of mitochondrial biogenetic capacity;
dysregulation of lipid, amino acid, glucose, nucleotide and amino acid
metabolism; changes in mitochondrial gene expression and protein abundance;
and evidence of alterations in autophagy and possibly mitophagy. Our results
are consistent with the view that constant nutrient excess shifts adipocyte
metabolic activity from energy provision to lipid storage. We speculate that the
decrease in mitochondrial biogenetic capacity and later removal of mitochondria
may also be a response to limit excessive lipid oxidation and oxidative stress and
to promote fat storage. Further studies are required to assess the significance of
each of the metabolic alterations and to test whether therapeutically targeting
these pathways is a gainful strategy for preventing obesity and its unfortunate
metabolic consequences.
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CHAPTER 3
REGULATION OF ADIPOSE TISSUE STEM CELL POPULATIONS BY
OBESITY

Introduction
Storing lipid in the form of esterified fat is the primary function of white
adipose tissue. Adipose tissue can expand to increase lipid uptake in two ways,
via adipocyte hypertrophy or hyperplasia (16, 57). Adipocytes can hypertrophy to
accommodate massive lipid loads; however when maximum expansion is
achieved, adipocytes begin to die by way of necrosis leading to an increase in
adipose tissue inflammation, hypoxia, and insulin resistance (56, 57, 166, 167).
Adipose tissue expansion has been shown to occur in this manner with
prolonged consumption of HFD (15). Adipocyte progenitor cells (APCs), which
can give rise to mature adipocytes, have been shown to proliferate and
differentiate allowing for expansion of adipose tissue by way of hyperplasia. This
type of expansion appears to maintain metabolic homeostasis, suggesting
hyperplasia is a more metabolically favorable form of adipose tissue remodeling
(37, 66).
Putative APCs have been described as cells expressing CD24 and CD29
and can be isolated from both bone marrow and adipose tissue. Rodeheffer, et
al. showed that when these cells, when transplanted into insulin resistant,
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lipodystrophic mice, proliferated, differentiated, and gave rise to a functional
adipose organ capable of storing lipid. The development of this tissue improved
insulin sensitivity in the transplanted animals (37). While APCs are required to
improve the fat storage capacity of adipose tissue, several types of supporting
cells would be required. For example, to sustain proper tissue oxygenation in
expanding tissue and to nurture newly formed, APC-derived adipocytes, the
vasculature network would need to grow in tandem with the expanding adipose
organ. Thus, endothelial progenitor cells (EPCs), which have been shown to
repair damaged endothelium and support the formation of new blood vessels in
vivo (168-171), would likely be in high demand during periods of increased fat
storage. In mice, Sca-1+ Flk1+ cells have been identified as EPCs and are
believed to have the capacity to differentiate into mature vascular networks,
promote vascular stability, or support angiogenesis (71, 76).
Chronic adipose tissue inflammation and hypoxia are known to
accompany the development of obesity, and these processes, in addition to
metabolic changes (15, 55, 56, 172), could negatively affect adipose tissue stem
cell populations. Nevertheless, the impact of obesity on these cell progenitor cell
populations is not clear. Because both an adequate amount of adipocytes and
oxygen availability are necessary to remodel adipose tissue, we hypothesize that
the balance of CD24+ CD29+ APCs and Sca-1+ Flk1+ EPCs is crucial for
favorable adipose tissue expansion. A better understanding the changes that
occur in progenitor cell populations of adipose tissue could be beneficial in
determining new treatments for obesity.
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To track the progenitor cell populations of interest, we performed a bone
marrow transplant, replacing bone marrow of wild-type mice with GFP positive
bone marrow cells. Donor bone marrow cells and progeny expressed GFP which
was detectable in the stromal vascular fraction (SVF). Analysis of SVF using flow
cytometry allowed us to quantify changes in the APC and EPC populations after
12 weeks of HFD as well as to determine the origin of each cell type. Results
from this study show that obesity increases the ratio of APCs to EPCs in adipose
tissue. Moreover, we find that more than 96% APCs are bone marrow-derived,
unlike EPCs which appear to be primarily tissue-resident. These data provide
fundamental information regarding the source of stem cells in adipose tissue and
suggest that changes in the number or function of angiogenic and adipogenic
progenitor cell populations may be an important feature of adipose tissue
remodeling.

Experimental procedures
Animal Studies: All procedures were approved by the University of Louisville
Institutional Animal Care and Use Committee. All mice used in these studies
were purchased from The Jackson Laboratory (Bar Harbor, ME).
Four week old C57BL/6J (wild-type; WT) mice were acclimated to the
animal facility for one week before being subjected to 10 minutes of total body
irradiation at a dosage of 950cGy by way of a cesium source (173). Twenty-four
hours after irradiation, bone marrow from 8 week old male mice expressing
“enhanced” green fluorescent protein (EGFP; The Jackson Laboratory, #006567)
75

was isolated and used to transplant irradiated WT mice via a single retro-orbital
injection. Approximately, 1×107 bone marrow stromal cells were injected into
each mouse using 100µl sterile PBS as the vehicle (Scheme 2). Five weeks after
transplantation, at 9 weeks of age, bone marrow transplanted (BMT) mice were
placed on either a 10% low fat diet (LFD; Research Diets, Inc., #D12450B) or a
60% high fat diet (HFD; Research Diets Inc., #D12492) for 12 weeks. Water and
diet were provided ad libitum and body weights were recorded weekly. To assess
proliferative capacity of adipose tissue-resident stem cells, 33mg/kg/day
bromodeoxyuridine (BrdU) was administered via i.p. injection each day for 7 days
prior to euthanasia.
Separate cohorts of WT mice, not subjected to BMT, were maintained on
LFD or HFD for 12 weeks. These animals received water and food ad libitum and
body weights were measured on a weekly basis for the duration of the study. At
the time of euthanasia, wet organ weights were measured and recorded to
assess potential differences between study groups.
Body composition measurement: Lean mass, fat mass, percent body fat, and
total body mass were measured by Dual X-ray Absorptiometry (DEXAscan)
paired with a mouse densitometer (PIXImus; Lunar, Madison, WI). For this
measurement, the body weight of each mouse was taken prior to the scan and
animals were anesthetized with isofluorane gas for the duration of the
DEXAscan. Measurements for each parameter were recorded and images of
each animal were collected.
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Activity assessment: Total activity level, ambulatory counts, fine movements, and
respiratory exchange ratio (RER) were measured using a physiological/metabolic
cage system (TSE PhenoMaster System; Bad Homberg, Germany). The mice
were singly housed throughout the entire assessment. Cages were located in a
temperature controlled room and when the light cycle was also regulated to allow
for 12 hours of light and 12 hours of darkness.
Glucose and Insulin Tolerance Tests: After a 6 h fast, a bolus of glucose (1.0
mg/g in sterile saline) was injected i.p. and blood glucose measurements were
recorded over the course of 2 h using blood collected from the tail vein. For
insulin tolerance tests, a bolus of insulin (1.5 U/kg Humulin R in sterile saline)
was injected i.p. into non-fasted mice and blood glucose was measured over a 2
h period.
Isolation of adipose stromal vascular fraction: The stromal vascular fraction
(SVF) was isolated from the visceral and subcutaneous adipose depots. The
adipose tissue was finely minced and digested in collagenase (500CDU/mL
PBS/HEPES) at 37°C for 25 min. The mixture was then filtered to remove any
particles larger than 100 µm and washed several times to remove excess
collagenase from the cell fraction.
Analysis of adipose tissue by flow cytometry: SVF cells were isolated as
previously described in this chapter and used for flow cytometric analysis. The Fc
receptor was blocked for 10 min at 4°C to prevent non-specific antibody binding.
The diverse SVF population was then stained for 30 min at 4°C with antibodies to
detect each of the following cell populations: adipocyte progenitor cells (Sca-1,
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CD24, CD29, CD90.2), endothelial progenitor cells (Sca-1, Flk1), leukocytes
(CD45), monocytes (CD14), macrophages (F4/80, CD11c, and CD301), T cells
(CD3, CD4, and CD8), B cells (B220/CD45R), and granulocytes (GR-1). All
antibodies (purchased from eBioscience or Biolegend) were conjugated to
unique fluorochromes for detection in 2 or more distinct panels. Samples were
analyzed using the BD LSR II and FACSDiva Software. Experiment files were
exported and further analyzed using the FlowJo analysis software.
WT, C57BL6/J mice from the Jackson Laboratory were used as bone
marrow cell recipients for this study. Mice expressing EGFP were used as bone
marrow cell donors. We chose to use these mice as donors so that we could
identify cell origin. Since donor cells expressed GFP, any cell which also
expressed GFP was deemed to be a bone marrow-derived cell. Therefore, GFPcells were deemed tissue resident cells.
Assessment of proliferation in adipose tissue: Immunofluorescent staining of
adipose tissue sections was performed with aid from the Pathology CORE at the
Diabetes and Obesity Center. Staining for transplanted cells, BrdU, and cell
nuclei were done using primary antibodies against the following proteins: GFP,
BrdU, and DAPI, respectively. Distinct fluorescent secondary antibodies were
used to detect each of the primary antibodies. The Zeiss confocal microscope
belonging to the Department of Molecular Cardiology at the University of
Louisville was used to generate images of the fluorescent-stained adipose tissue
sections. The Carl Zeiss ZEN 2012- blue edition was used to capture and
analyze each of the confocal images. Cell expression of GFP, BrdU, and Dapi
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were quantified independently using the Nikon Elements-Basic Research
software package. To determine proliferative capacity of bone marrow-derived
cells, cells expressing both GFP and BrdU were also quantified.
Statistical Analyses: Statistical analyses were performed using the Prism
GraphPad software. For direct comparison of two groups, Student’s t test was
used. For comparison of multiple groups, one-way or two-way analysis of
variance tests (ANOVA) were used with Bonferroni post-testing. Data are
expressed as mean + standard error of the mean (SEM) unless otherwise noted.
Significant differences between groups are marked on the graph with “*” denoting
p value<0.05, “**” denoting p value<0.01, and “***” denoting p value<0.0001.
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Scheme 2
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Scheme 2: Bone marrow transplantation protocol. Bone marrow was isolated
from both hind limbs of 8 week old, male EGFP donor mice. These cells were
harvested in sterile isolation medium, washed, filtered and reconstituted in sterile
PBS for transplantation. Anesthetized animals were then given bone marrow
cells via retro-orbital injection. Mice were closely monitored for 10 days to ensure
recovery from the transplant. During this time, mice were fed normal chow and
given water, by way of water bottles, ad libitum. Five weeks post-transplantation,
mice were fed a 10% low fat or 60% high fat diet for the duration of the study.
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Results
Adiposity is significantly increased after 12 weeks of high fat diet. Because
12 weeks of HFD has been suggested to promote maximal adipocyte
hypertrophy and result in metabolic changes that promote a pre-diabetic state
(15, 54, 56), this model was used to elucidate the impact of obesity on adipose
stem cells. For this, WT, C57BL6/J mice were fed either a 10% LFD or 60%
HFD ad libitum for 12 weeks. Total body mass and total weight gain were
significantly increased with consumption of HFD (Figure 11A,B). After 12 weeks
of feeding, body composition was measured using Dexascan (Figure 11C,D).
Dexascan analysis showed 12 weeks of HFD increased total body mass by 1.7fold (Figure 11E). Lean mass, which accounts for muscle and bone mass, was
unchanged (Figure 11F). However, total fat mass increased 2-fold (Figure 11G)
and fat mass as a percentage of the total body mass increased 3.5-fold (Figure
11H) after 12 weeks of HFD.
Consumption of high fat diet decreases activity. To examine the impact of
obesity on metabolic and physiological activity, we placed obese and lean mice
in metabolic cages for 24 hours. Beams along the bottom of the cage were used
to determine the type, fine or ambulatory, and duration of movement. Each beam
break was counted and the total number of beam breaks per 10 min interval was
recorded and quantified (Figure 12). Twelve weeks of HFD decreased total
movements 1.9-fold (Figure 12 A,B). Ambulatory movement counts were
diminished 2.1-fold with HFD (Figure 12 C,D) and fine movements declined 1.5fold (Figure 12 E,F). Respiratory exchange ratio was also decreased
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significantly, 0.9009 ± 0.003135 with LFD and 0.7712 ± 0.001059 with HFD
(Figure 12 G,H).
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Figure 11
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Figure 11. Adiposity increases significantly after consumption of a 60% fat
diet for 12 weeks. Total body weight gain, (A), and delta body weight gain (B),
are plotted in grams. Representative photographs and Dexascan images of mice
fed a 10% low fat or 60% high fat diet for 12 weeks are provided above, (C) and
(D), respectively. Total body mass, (E), lean mass, (F), and fat mass, (G), were
quantified and presented in grams of tissue. Total fat mass is expressed as a
percentage of the total body mass, (H); n = 4-6 per group; *p<0.05, **p<0.01, and
***p<0.001 vs. LFD.
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Figure 12
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Figure 12: Consumption of high fat diet decreases activity. Male WT
C57BL/6J mice were fed a low fat diet (LFD, 10% kcal fat) or high fat diet (HFD,
60% kcal fat) for 12 weeks and the following measurements were recorded and
means were quantified: Total activity level, (A) and (B); ambulatory counts, (C)
and (D); fine movements, (E) and (F); and respiratory exchange ratio (RER), (G)
and (H). n = 6 per group; ***p<0.001 vs. LFD.
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Whole body glucose tolerance is significantly reduced by long-term
consumption of a 60% high fat diet for 12 weeks. Mice fed a HFD had
elevated blood glucose levels following a glucose challenge and area under the
curve was increased 1.6-fold above LFD group (Figure 13A,B). There was not a
significant difference in insulin tolerance (Figure 13D). Together, these data
suggest that glucose tolerance is impaired due to diet-induced obesity.
Visceral adipose depot expands tremendously with 12 weeks of high fat
feeding. To examine gross changes in size, wet tissue wets of several organs
were measured after the establishment of obesity. In this case, both epididymal
fat pads were harvested and weighed together to yield a total visceral adipose
tissue measurement, vWAT. There was a marked, 5-fold increase in the mass of
the visceral adipose tissue of the mice fed a HFD (Figure 14). Since the visceral
white adipose tissue was most significantly changed with obesity, we next
assessed changes in the cell composition of visceral adipose tissue.
Total T cell and macrophage populations increase significantly in visceral
adipose tissue with obesity. To examine the inflammatory status of the adipose
tissue, F4/80 positive cells (macrophages) and CD3 positive cells (T cells) were
examined in the stromal vascular fraction isolated from the visceral and
subcutaneous adipose tissue. Only the visceral adipose tissue showed significant
differences in the total number of inflammatory cells per gram tissue due to high
fat feeding, furthering support for the argument that the visceral adipose tissue is
most significantly affected by the development of diet-induced obesity in our
model. There was a 2.9-fold increase in F4/80 positive macrophage cells and a
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1.9-fold increase in CD3 positive T cells in the visceral adipose tissue after 12
weeks of HFD (Figure 15A,C).
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Figure 13
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Figure 13. Measurements of insulin sensitivity in WT mice after 12 weeks of
high fat diet. After 12 weeks of a LFD or HFD, a glucose tolerance test, (A), and
insulin tolerance test, (C), was performed on a cohort of obese mice. Area under
the curve for the glucose tolerance test was calculated and expressed as such in
graph (B). Area under the curve was calculated and normalized to the baseline
glucose measurement for the insulin tolerance test, graph (D). For each
measurement, n = 4 per group; ***p<0.001 vs. LFD.
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Figure 14
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Figure 14. Wet tissue weight of organs harvested from animals fed LFD or
HFD for 12 weeks. After 12 weeks of feeding, tissues were collected from each
of the mice and the wet weights are quantified above (A); n=6 per group;
***p<0.001 vs. LFD.
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Figure 15
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Figure 15. Quantification of F4/80+ and CD3+ cell populations in visceral
and subcutaneous adipose tissue after consumption of 60% high fat diet
for 12 weeks. The quantification for the total number of F4/80+ macrophage
cells per gram of visceral or subcutaneous adipose tissue are presented above;
graphs (A) and (B), respectively. Quantification of the total CD3+ T cells per
gram of visceral or subcutaneous adipose tissue is also included in the figure; (C)
and (D), respectively; n=7-8 per group; *p<0.05 vs. LFD.
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Imbalance in progenitor cells pools in the visceral adipose tissue of obese
mice. Adipocyte progenitor cells, APCs, and endothelial progenitor cells, EPCs,
were identified as outlined in Scheme 3. To understand the diet-induced changes
in these two populations, APCs and EPCs were identified in the stromal vascular
fraction, SVF, using flow cytometry. Each SVF sample was stained with
antibodies to detect cell surface antigens of interest. Based upon the expression
of these antigens, the CD14- CD45- CD24+ CD29+ APCs and CD14- CD45Sca-1+ Flk1+ EPCs were identified and quantified (Figure 16A,B). Though there
was no significant difference in the number cells per gram fat with HFD, the ratio
of APCs to EPCs was increased more than 5-fold in the high fat fed group
(Figure 16C).
Adipocyte progenitor cells in visceral adipose tissue of obese mice are
bone marrow-derived. To determine the origin of the progenitor cell populations
of interest, a bone marrow transplant was performed. Recipient mice were
treated with a lethal dose of irradiation to eradicate all existing bone marrow
cells. These cells were repopulated with GFP positive donor cells 24 hours after
irradiation. To allow for proper repopulation, mice were monitored and
maintained on normal chow for 5 weeks before they were placed on a low fat or
high fat diet or 12 weeks. Bone marrow-derived, GFP positive APCs accounted
for >96% of all APCs identified in the visceral stromal vascular fraction of both
low fat and high fat fed mice (Figure 17B,C). Conversely, >80% of EPCs were
GFP negative, indicating that most EPCs in the visceral adipose tissue stromal
vascular fraction derive from a tissue-resident pool (Figure 17E,F).
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Proliferation of adipose tissue stromal cells is decreased after 12 weeks of
HFD. BrdU was detected via histological analysis of paraffin-embedded visceral
adipose tissue sections. The percentage of total DAPI positive cells expressing
BrdU was decreased 1.48-fold HF-fed mice compared to mice fed LFD (Figure
18A). BrdU positivity of bone marrow-derived cells expressing GFP was not
different between the groups (Figure 18B). These data suggest that proliferation
of adipose tissue-resident stromal cells, whereas proliferation of bone-marrow
derived cells is unaffected, by HFD.
Reversion from 60% HFD to 10% LFD decreases adiposity and restores
insulin sensitivity. We established a model of obesity by feeding 8 week old
C57BL6/J mice a 60% HFD for 12 weeks and then reverted the animals to a 10%
LFD for 4 weeks to determine if weight loss improved insulin sensitivity in mice.
The reverted cohort experienced a significant amount of weight loss and after 4
weeks of LFD, the percent weight gain measured in the reverted cohort was no
longer different from that of the cohort fed a LFD for the entire 16 week period
(Figure 19A). Area under the curve for the glucose and insulin tolerance tests
was decreased significantly after reversion to LFD and was not significantly
different from the LFD group (Figure 19D,E).
Progenitor pools are increased after reversion of obese mice to a 10% low
fat diet. Adipocyte progenitor cells, APCs, and endothelial progenitor cells,
EPCs, were identified as previously described. To examine changes in the
progenitor cell populations with weight loss, obese, HFD group was compared to
the reverted, HFD-LFD, group. The weight loss induced a 7.7-fold increase in
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APCs and a 4.4-fold increase in EPCs (Figure 20A,B). The ratio of APCs to
EPCs was also increased 1.5-fold (Figure 20C) compared to the HFD fed mice.
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Scheme 3
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Scheme 3. Progenitor cell identification. The diagram above depicts the
method used to discriminate progenitor cell populations from the heterogeneous
stromal vascular fraction. The same hierarchy is used to identify progenitors in
other heterogeneous depots, such as bone marrow or blood.
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Figure 16
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Figure 16. Quantification of adipocyte progenitor cell, APC, and endothelial
progenitor cell, EPC, populations of visceral adipose tissue after
consumption of 60% high fat diet for 12 weeks. The quantification for the
total number of CD14- CD45- Sca-1+ CD24+ CD29+ APCs per gram of visceral
adipose tissue are presented above in graph (A). Quantification of the total
CD14- CD45- Sca-1+ Flk-1+ EPCs per gram of visceral adipose tissue is also
included in graph (B). The ratio of APCs to EPCs is presented in graph (C); n=6
per group, *p<0.05 vs. LFD.
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Figure 17
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Figure 17. Quantification of adipocyte progenitor cell, APCs, and
endothelial progenitor cell, EPC, populations of visceral adipose tissue
after bone marrow repopulation and consumption of 60% high fat diet for
12 weeks. After bone marrow transplantation with GFP+ stromal cells, mice were
placed on 10% LFD or 60% HFD for 12 weeks. The quantification for the total
number of CD14- CD45- Sca-1+ CD24+ CD29+ APCs per gram of visceral
adipose tissue are presented above in graph (A). GFP+ and GFP- APC
populations of in the LF, (B), and HF (C), cohorts are quantified as cells per gram
tissue. Total CD14- CD45- Sca-1+ Flk-1+ EPCs in the visceral adipose tissue of
bone marrow transplanted animals is presented as cells per gram tissue, (D).
GFP+ and GFP- EPC populations of in the LF, (E), and HF (F), cohorts are
quantified as cells per gram tissue. APCs to EPCs ratio is provided in graph (G);
n=7-8 per group; *p<0.05, **p<0.01, and ***p<0.001 vs. LFD.
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Figure 18
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Figure 18. Quantification of BrdU in adipose tissue after 12 weeks of LFD or
HFD. Quantification of the total percentage of BrdU+ cells are presented in graph
(A). GFP+ BrdU+ cells in the visceral adipose tissue are also presented as a
percentage of the total Dapi+ cell population (B); n= 4 mice/group (4-5
images/animal) for LFD and n=4 mice/group (5-10 images/animal) for HFD;
*p<0.05 vs. LFD.
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Figure 19
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Figure 19. Changes in adiposity, glucose tolerance, and insulin tolerance
after reversion to 10% LFD. Weekly weight gain was quantified and presented
as percentage of the initial body weight, (A). Blood glucose levels after 6 and 16
hour fast can be found in graph (B). Changes in blood glucose level during a
glucose tolerance test is presented in mg/dL, (C), and the area under the curve is
quantified to the right, (D). Insulin induced changes in blood glucose level are
plotted in (E) and quantification of area under the curve is presented in graph (F);
n=8-18 per group; *p<0.05, **p<0.01, and ***p<0.001.
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Figure 20
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Figure 20. Quantification of adipocyte progenitor cell, APC, and endothelial
progenitor cell, EPC, populations of visceral adipose tissue after
consumption of 60% high fat diet for 12 weeks and reversion to 10% LFD
for 4 weeks. The quantification for the total number of CD29+ APCs per gram of
visceral adipose tissue are presented above in graph (A). Quantification of the
total number of Sca-1+ Flk-1+ EPCs per gram of visceral adipose tissue is also
included in graph (B). The ratio of APCs to EPCs is presented in graph (C); n=910 per group, *p<0.05, **p<0.01, and ***p<0.001 vs. HFD.
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Discussion
The major findings of this study reveal that progenitor cell balance may be
essential to promote protective adipose tissue remodeling and that adipocyte
progenitors are recruited from the bone marrow under conditions of nutrient
excess. Our data show that 12 weeks of 60% HFD is sufficient to induce an
obese phenotype in wild-type mice. Mice fed HFD exhibited impaired glucose
tolerance, decreased physical activity, and increased body fat mass, primarily
due to expansion of the visceral adipose tissue depot. This increase in adiposity
increased the ratio of APCs to EPCs by 5-fold. Lineage tracing experiments
confirmed that putative APCs are derived from bone marrow and that Sca-1+
Flk1+ EPCs are primarily resident to the tissue. While it has been shown that
APCs can differentiate into mature adipocytes in vivo, the significance of the
proportion of adipogenic and angiogenic precursors necessary to promote
protective adipose tissue remodeling has not be fully described (37, 66).
Our data show a 2.9-fold increase in macrophages and 1.9-fold increase
in T cells after 12 weeks of HFD, which is in accordance with numerous studies
showing that obesity promotes a chronic state of inflammation (55-57, 167, 174).
Adipose tissue hypoxia has also been described to occur with obesity and is
implicated as a potential contributor to the development of insulin resistance (5559, 172). EPCs have the capacity to repair damaged endothelium and to create
new blood vessels in vivo (68, 69, 71, 79-82). We did not see a significant
change in EPC number after 12 weeks of HFD, but the increase in APC to EPC
ratio could be indicative of a diet-induced change in the stem cell composition of

111

adipose tissue; one which might impact adipose tissue remodeling. It is important
to note, more than 96% of Sca-1+ Flk1+ cells were GFP- in mice consuming
HFD, suggesting bone marrow-derived EPCs are not likely recruited to the
adipose tissue during obesity. Moreover, we find that HFD appears to decrease
the proliferation of tissue-resident cells, suggesting that, these resident EPCs
might have decreased proliferative capacity and contribute to pathological
adipose tissue remodeling. This is important because decreased levels of these
pro-angiogenic cells have been implicated in the development of several chronic
diseases including cardiovascular disease, due likely to a diminished capacity to
repair damaged vasculature (73-78). Obesity along with exposure to other
environmental factors, i.e. air pollution and cigarette smoke, have been shown to
negatively affect EPC numbers and function (68, 69, 71, 72).
The imbalance of APCs to EPCs is an interesting finding of this study.
Protective adipose tissue remodeling is characterized by the presence of large
numbers of small adipocytes, decreased adipose tissue inflammation, and
maintenance of metabolic homeostasis (56, 62, 63). APCs have been shown to
proliferate, differentiate, and take up esterified lipid, expanding the adipose tissue
(37). Our studies show that HFD increases these cells in visceral adipose tissue
and that this increase may be due to increased recruitment from the bone
marrow since >96% of APCs were GFP+. The tissue-resident origin of the
unchanged Sca-1+ Flk1+ EPC population in visceral adipose tissue could
provide insight into the preference for pathological remodeling under conditions
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of nutrient excess. Correcting the imbalance of these two cell types could be
important in the discovery of novel therapeutic treatments for obesity.
Addressing the question of whether the ratio of APCs to EPCs is crucial in
promoting protective adipose tissue remodeling in conditions of nutrient excess
would require interventions to correct the imbalance of these two cell populations
in adipose tissue. Increasing the EPC population by way of cell transplantation or
stimulation of EPCs to mobilize from the bone marrow to visceral adipose tissue
with HFD are two methods by which this could be addressed. However, we have
observed that subjecting mice to repeated injections can prevent body weight
gain (unpublished observations). Because the goal of these studies would be to
examine the adipose tissue remodeling process, the decreased weight gain
could skew results. To mobilize the bone marrow EPCs pharmacologically, it
would be advantageous to select an agent with minimal interactions with other
progenitor cell types so that the contribution of mobilized cells to the remodeling
processes could be clearly discerned.
In summary, our work provides information about the origins of adipose
tissue stem cells and the diet-induced changes in their relative abundance. We
find that 12 weeks of HFD substantially increases gross tissue mass and
inflammation, which was associated with increases in the ratio of APCs to EPCs.
We also find that APCs appear to derive from the bone marrow and that Flk+
Sca+ EPCs are primarily tissue-resident. The observation that tissue-resident
stromal cells had lower BrdU positivity suggests that this population of EPCs
could have defective proliferative capacity during conditions of nutrient excess.
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Overall, these findings support our hypothesis that obesity impairs adipose tissue
remodeling by negatively affecting stem cells and lends insight into a possible
mechanism, i.e., that obesity impairs proliferation of adipose tissue-resident
EPCs, leading to a decreased capacity to provide vascular support to forming,
newly formed, or mature adipocytes.
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CHAPTER 4
CONTRIBUTION OF STEM CELLS TO ADIPOSE TISSUE REMODELING

Introduction
Stem cells play an important role in tissue homeostasis and repair (16, 56,
63, 70, 71, 175). Mesenchymal stem cells (MSCs) have been successfully
isolated from multiple tissues including skeletal muscle, adipose tissue, and bone
marrow (37, 66, 176-178). These cells have also been shown to be give rise to
several cell types including skeletal muscle, heart, joint, bone, and adipose tissue
(177, 179-181). MSCs isolated from skeletal muscle are relatively easy to obtain
via muscle biopsy. Satellite cells, progenitor cells which are known to give rise to
myoblasts, are located in close proximity to myofibers and though many of these
cells are committed to the myogenic lineage, these CD29 positive cells can also
undergo chondrogenic, endothelial, and osteogenic differentiation (177, 180,
181). Bone marrow-derived cells expressing early cardiac markers as well as
Sca-1, CD34 and AC133 have been shown to migrate to the damaged
myocardium post myocardial infarction and are believed to be involved in repair
of myocardium (179). In adipose tissue, there is a vast pool of progenitor cells
including adipocyte progenitors (APCs), which can differentiate into mature
adipocytes, and endothelial progenitors (EPCs), which promote the formation of
new blood vessels as well as provide support for existing vasculature. There is
also evidence that these adipose tissue stem cells can impose paracrine effects,
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stimulating the migration of endothelial cells to prevent neointimal formation and
promote vascular repair (37, 52, 66, 169, 182, 183). Since stem cells play a role
in several organ systems, the competency and levels of these cells could be
crucial to their ability to provide adequate tissue support; however, both of these
characteristics can be affected by several factors (52, 68, 69, 73, 75, 82, 168).
In adipose tissue, increased levels of stem cells could be indicative of
favorable adipose tissue remodeling. Increasing these cell populations may allow
for massive expansion of adipose tissue in response to HFD, while maintaining
metabolic homeostasis. This results in the development of a benign state of
morbid obesity predicated by an increased number of small adipocytes and
systemic insulin sensitivity. For example, increased levels of adiponectin, a
hormone secreted by adipose tissue, stimulated adipocyte progenitors to
differentiate. In so doing, lipid uptake and energy expenditure of white adipose
tissue are increased (62, 63).
In the obese condition, adipocytes can expand tremendously to
accommodate the excess lipid load, and in some cases, adipocytes hypertrophy
to 10,000 µm in diameter (184). Since oxygen has a limited diffusion capacity in
which it can only supply cells within a close proximity to a functional capillary
bed, such an increase in adipocyte area creates a hypoxic environment in obese
adipose tissue (58, 185-187). Hypoxic conditions have been shown to inhibit
adipogenic differentiation of mesenchymal stem cells (MSCs) from bone marrow
and adipose tissue (188-191). Hypoxia also has an effect on the endocrine
function of adipose tissue, suppressing production of adiponectin by adipocytes
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(185, 186, 192, 193). Adiponectin is a hormone which has been shown to support
proliferation of adipocytes as well as decrease inflammation in adipose tissue
and vasculature (194). Adipose tissue of obese, transgenic mice that
overexpress adiponectin, have been shown to have an increased number of
smaller adipocytes when compared to obese controls (63). Adiponectin also acts
on endothelial cells to increase the production of nitric oxide (194), which is
significantly decreased with obesity (109). Nitric oxide (NO) plays a role in a host
of physiological processes including the regulation of blood flow, angiogenesis,
and vasodilatation. In addition, NO and other reactive oxygen species have been
shown to increase differentiation of preadipocytes or APCs in vitro (195-197).
When preadipocytes were treated with an NO releasing agent, hydroxylamine, or
a substrate of nitric oxide synthase, L-arginine, lipoprotein lipase and glycerol-3phosphate dehydrogenase were increased indicating adipogenic differentiation.
Inducible nitric oxide synthase (iNOS) and endothelial nitric oxide synthase
(eNOS) were both upregulated in differentiating cells, however differentiation was
uninterrupted upon inhibition of iNOS suggesting that eNOS may have a more
significant role in adipogenic differentiation of preadipocytes (197).
Data from our previous study show no significant change in the number of
adipocyte progenitor and endothelial progenitor cells after 12 weeks of high fat
feeding. However, the ratio of the two cell populations is significantly increased
with HFD. As previously described, both endothelial and adipocyte progenitor
cells are necessary for the positive remodeling of the adipose tissue. Since
obesity disrupts the balance of these two progenitor populations, we chose to
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examine if correcting this imbalance might support a more metabolically
favorable adipose tissue remodeling, improving diet-induced glucose intolerance
and decreasing adiposity. To do so, we increased the EPC population in adipose
tissue of mice fed HFD by cell transplantation in an attempt to correct the APC to
EPC ratio associated with HFD. As an additional way of potentially improving
vascular function, we also sought to determine if increasing expression of eNOS
in bone marrow-derived cells would support favorable adipose tissue remodeling
by increasing APC differentiation or increasing vascular perfusion.
To supplement EPCs in adipose tissue of obese mice, we performed a
direct cell transplantation of bone marrow-derived EPCs isolated from wild-type
or eNOS-Tg mice into visceral adipose tissue. After 12 weeks of 60% HFD, mice
transplanted with eNOS-Tg bone marrow showed no difference in adipocyte size,
glucose, or insulin tolerance when compared to WT transplanted group.
However, there was an appreciable increase in adipose tissue vascularity of high
fat-fed mice transplanted with eNOS-Tg bone marrow. Results from this study
suggest that increasing the competency or number of progenitor cells may
support angiogenesis in the obese condition.

Experimental procedures
Animal Studies and Procedures: All procedures were approved by the University
of Louisville Institutional Animal Care and Use Committee. Four week old
B6.SJL-Ptprca Pepcb/BoyJ (Pep Boy; wild-type; WT) mice were purchased from
The Jackson Laboratory (Bar Harbor, ME). The mice were given several days to
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acclimate to the animal facility before being subjected to a lethal dose of Ɣradiation (950cGy) by way of a cesium source (173). Twenty-four hours after
irradiation, bone marrow from 8 week old male eNOS-Tg and WT mice was
isolated and used to transplant irradiated WT mice via a single retro-orbital
injection. Approximately, 1×107 bone marrow stromal cells were injected into
each mouse using 100µl sterile PBS as the vehicle. The WT mice were
purchased from The Jackson Laboratory (Bar Harbor, ME) and the colony of
eNOS-Tg mice was maintained at the University of Louisville. The transgenic
mice were developed on a C57BL/6J background and the animals overexpress
bovine eNOS due to manipulation of the preproendothelin-1 promoter. Five
weeks after transplantation, at 9 weeks of age, bone marrow transplanted (BMT)
mice were placed on either a 10% low fat diet (LFD; Research Diets, Inc.,
#D12450B) or a 60% high fat diet (HFD; Research Diets Inc., #D12492) for 12
weeks. Water and diet were provided ad libitum and body weights were recorded
each week.
Cell isolation: Bone marrow stromal cells were isolated from the tibia and femur
of both hind limbs of 8 week old GFP positive mice (The Jackson Laboratory,
#006567). The cells were flushed from the bones using a sterile solution of PBS
with 10% FBS and a 24G-needle and syringe and kept on ice until all cells had
been isolated. Once the cells were isolated, the cell solution was underlayed with
Fico/Lite-LymphoH (Atlanta Biologicals, I40150) in a 1:1 fashion in sterile conical
tubes. The tubes were then centrifuged for 20 minutes at 1500G at 18⁰ C. The
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interphase layer, or buffy coat, was carefully removed and the cells were washed
twice.
The stromal vascular fraction (SVF) was isolated from the visceral and
subcutaneous adipose depots. The adipose tissue was finely minced and
digested in collagenase (500CDU/mL PBS/HEPES) at 37⁰ C for 25 minutes. The
mixture was then filtered to remove any particles larger than 100µm and washed
several times to isolate the SVF cells for analysis.
Cell culture: The isolated cells were cultured on Fibronectin-coated (SigmaAldrich, F0895) 6 well dishes with 2mL of culture medium. The culture medium
consists of EBM-2 basal medium (Lonza, CC-3156), EGM-2 SingleQuot Kit
supplements and growth factors (Lonza, CC-4176), FBS (Atlanta biologicals,
S11150H) and Penicillin-Streptomycin solution (Gibco, 15070-063). 48 hours
after seeding the cells, the medium was refreshed. Medium was then changed
every 24 hours for the next 3 days, then every 2 days until the cells were
confluent.
EPCs were removed from confluent 6 well plates using trypsin and
neutralized with trypsin neutralization solution. This process usually takes some
time because the cells tend to adhere tightly to the culture dish. 500µl trypsin was
placed in each well for 5 minutes and then neutralized with 1mL of solution. This
process was repeated 2 more times to remove the majority of the cells. The cells
were the washed with PBS and centrifuged at 500G for 5 minutes to pellet the
cells.
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Endothelial Progenitor Cell transplantation: An aliquot of EPCs was used to
calculate a total cell count, then aliquots of 1x107 cells were then placed into
sterile Eppendorff tubes. The cells were then combined with Matrigel to bring the
final volume to 500µl. The solution was injected into the epidiymal fat pads of
obese mice at 6 injection sites, 3 per pad, using a 24G-needle and syringe. Mice
were monitored for 10 days post cell transplantation.
Body composition measurement: Lean mass, fat mass, percent body fat, and
total body mass were measured by Dual X-ray Absorptiometry (DEXAscan)
paired with a mouse densitometer (PIXImus; Lunar, Madison, WI). For this
measurement, the body weight of each mouse was taken prior to the scan and
animals were anesthetized with isofluorane gas for the duration of the
DEXAscan. Measurements for each parameter were recorded and images of
each animal were collected.
Glucose and Insulin Tolerance Tests: After a 6 hour fast, a bolus of glucose
(1.0mg/g in sterile saline) was injected i.p. and blood glucose measurements
were taken over the course of 2 hours using blood collected from the tail vein.
For insulin tolerance test, a bolus of insulin (1.5U/kg Humulin R in sterile saline)
was injected i.p. into non-fasted mice and blood glucose was measured over a 2
hour period.
Adipocyte area measurement: Samples of adipose tissue were removed from the
visceral and subcutaneous depots. The samples were fixed in 10% formalin,
embedded in paraffin, sectioned, and stained with hematoxylin and eosin for
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histological assessment. Adipocyte number and area were quantified using the
Nikon Elements-Basic Research software package.
Immunostaining of adipose tissue: Isolectin was used to assess capillary density
in the adipose tissue sections as described in Sansbury, et al. Circ Res, 2012.
Staining for transplanted cells, adipocytes, and cell nuclei were done using
primary antibodies against the following proteins; GFP, perilipin, and dapi,
respectively. Distinct fluorescent secondary antibodies were used to detect each
of the primary antibodies. This was done in collaboration with the Pathology
CORE of the Diabetes and Obesity Center at the University of Louisville.
Imaging of adipose tissue: Images of the hematoxylin and eosin stained sections
were taken using a Zeiss microscope from SPOT Imaging Solutions. The Zeiss
confocal microscope belonging to the Department of Molecular Cardiology at the
University of Louisville was used to generate images of the fluorescent-stained
adipose tissue sections. The Carl Zeiss ZEN 2012- blue edition was used to
capture and analyze each of the confocal images.
Analysis of adipose tissue by flow cytometry: SVF cells were isolated as
previously described in this chapter and used for flow cytometric analysis. The Fc
receptor was blocked for 10 minutes at 4⁰ C to prevent non-specific antibody
binding. The SVF cells were then stained for 30 minutes at 4⁰ C with antibodies
to detect each of the following cell populations: adipocyte progenitor cells (Sca-1,
CD24, CD29, CD90.2), endothelial progenitor cells (Sca-1, Flk1), and
hematopoietic cells (Sca-1+ CD34+). All antibodies were (purchased from
eBioscience or Biolegend) conjugated to unique fluorochromes for detection in 2
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or more distinct panels. Samples were analyzed using the BD LSR II and
FACSDiva Software. Experiment files were exported and further analyzed using
the FlowJo analysis software.
The WT mice that we used as recipients for the bone marrow transplant
were “Pep Boy” mice ordered from The Jackson Laboratory. We chose to use
these mice as recipients because they express the cell surface antigen CD45.1
instead of CD45.2, unlike the C57BL6/J mice which are commonly used as our
WT model. The homozygous eNOS-Tg mice express CD45.2 so by using these
two strains, we were able to assess the efficacy of the eNOS-Tg bone marrow
transplant by flow cytometric analysis using antibodies against CD45.1 and
CD45.2 purchased from eBioscience.
Statistical Analyses: Statistical analyses performed using the Prism GraphPad
software. For direct comparison of two group, Student’s t test was used. For
comparison of multiple groups, one-way and two-way analysis of variance tests
(ANOVA) were used with Bonferroni post-testing. Data are expressed as mean +
standard error of the mean unless otherwise noted. Significant differences
between groups are marked on the graph with “*” denoting p value<0.05, “**”
denoting p value<0.01, and “***” denoting p value<0.0001.
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Results
Adipocyte area is unchanged 10 days after direct cell transplantation.
Hematoxylin and eosin staining of adipose tissue sections reveal an increase in
interstitial cells in visceral adipose tissue of obese mice compared to the
subcutaneous depot (Figure 21A). Further histological analysis would need to be
completed to determine the identity of these cells, however their presence might
be indicative of adipose tissue remodeling during which inflammatory cells, stem
cells, and extracellular matrix components are all significantly increased (56, 57,
175). Adipocyte area measurement shows no significant difference between
vehicle-treated and EPC-transplanted animals in either the visceral (vehicle,
6022 ± 330.6; EPC, 6345 ± 539.4) or subcutaneous (vehicle, 7435 ± 655.9; EPC,
7402 ± 723.2) adipose tissue depots (Figure 21B,C).
Transplanted cells engraft into capillaries of the visceral and subcutaneous
adipose tissue within 10 days. After GFP+ EPC transplant, adipose tissue
sections were fixed and stained to determine if integration of transplanted bone
marrow cells occurred. Cells which are co-stained with isolectin and GFP
represent transplanted bone marrow-derived cells which have integrated into the
existing vascular network or formed a new blood vessel. As seen in Figure 22,
several GFP positive cells in the visceral and subcutaneous adipose tissue of the
transplanted mice are also isolectin positive.
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Figure 21
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Figure 21. Hematoxylin and eosin stained paraffin-embedded visceral and
subcutaneous adipose tissue sections. Visceral, vWAT, and subcutatneous,
sWAT, adipose tissue sections from vehicle and EPC injected animals were
stained for histological assessment, (A). These images were taken at 20×
magnification. Average adipocyte area of cells in the visceral adipose tissue and
subcutaneous adipose tissue is quantified in graphs (B) and (C), respectively;
n=3 per group.
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Figure 22
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Figure 22. Representative confocal images of isolectin stained adipose
tissue sections. Samples of visceral and subcutaneous adipose tissue were
fixed in formalin, embedded in paraffin, sectioned, and stained to visualize GFP+
EPC integration into isolectin stained capillary networks. GFP negative and
positive controls as well as representative images of subcutaneous and visceral
adipose tissue from EPC-transplanted and vehicle-injected mice are presented,
(A) and (B), respectively.
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Transplantation of eNOS-Tg stromal cells increased total body mass after 12
weeks of HFD. Total body weight and weekly weight gain were significantly
increased with HFD in both mice transplanted with WT and eNOS-Tg bone
marrow (Figure 23E-H). Dexascan analysis showed that total body mass was
modestly increased (1.08-fold) in mice transplanted with eNOS-Tg bone marrow
compared with mice transplanted with WT bone marrow after 12 weeks of HFD
(Figure 23I). Percent body fat was increased 1.8-fold HFD in both the WT and
eNOS-Tg transplanted groups (Figure 23J). Regardless of the diet, average lean
mass was not different in mice transplanted with WT bone marrow; the lean
mass of mice in the HF eNOS-Tg group was 1.1-fold higher than that of the LF
eNOS-Tg group (Figure 23K). Fat mass increased 2.6-fold in eNOS-Tg
transplanted animals and 2.4-fold in WT transplanted animals after 12 weeks of
HFD (Figure 23L).
Systemic insulin sensitivity was not changed with transplantation of eNOS-Tg
bone marrow. Fasting blood glucose levels were elevated 1.3-fold in eNOS-Tg
HFD group compared to eNOS-Tg LFD after a 6 h fast (Figure 24A). After a 16 h
fast, glucose levels were 1.7-fold higher in HF WT compared with LF WT and
1.4-fold higher in HF eNOS-Tg compared with LF eNOS-Tg (Figure 24A).
Glucose and insulin tolerance tests showed a diet-dependent difference in area
under the curve; however there was no significant difference between WT and
eNOS-Tg transplanted groups (Figure 24D,G).
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Figure 23
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Figure 23. High fat diet increases adiposity in WT and eNOS-Tg bone
marrow transplanted animals. Representative pictographs and Dexascan
images of each group are presented and labeled accordingly, (A), (B), (C), and
(D). Total body weight, (E) and (G), and delta weight gain, (F) and (H), are
expressed in grams. Dexascan parameters, including total body mass (I), lean
mass (K), and fat mass (L), are plotted in grams of tissue. Body fat expressed as
a percentage of the total body mass is also included, graph (J); n = 4 per group;
*p<0.05, **p<0.01, and ***p<0.001.
.
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Figure 24
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Figure 24. Measurements of insulin sensitivity in bone marrow transplanted
animals after 12 weeks of high fat diet. After 12 weeks of a LFD or HFD,
fasting blood glucose levels were measured after a 6 and 16 hour fast, (A). A
glucose tolerance test, (B) and (C), and insulin tolerance test, (E) and (F), was
also administered. Area under the curve for the glucose tolerance test was
calculated and expressed as such in graph (D). Area under the curve was
calculated and normalized to the baseline glucose measurement for the insulin
tolerance test, graph (G); n = 4 per group; *p<0.05, **p<0.01, and ***p<0.001.
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High fat diet induces a progenitor cell imbalance in visceral adipose tissue.
APCs were not significantly changed after 12 weeks of HFD (Figure 25A). EPCs
were significantly decreased in all groups compared to LF WT (Figure 25B). APC
to EPC ratio showed a significant increase in both high fat-fed groups compared
to LF WT, 10.8-fold in HF eNOS-Tg and 10.2- fold in HF WT (Figure 25C). Since
CD34 positive cells have been shown to promote the formation of vasculature in
vivo (79, 169), changes in the CD34 positive cell population was also examined.
Similar to the endothelial progenitor cell population, CD34 positive cells were
decreased in high fat-fed groups, 3.4-fold in HF WT and 2.7-fold in HF eNOS-Tg
(Figure 25D).
Isolectin staining is increased in adipose tissue of mice transplanted with eNOSTg bone marrow after 12 weeks of HFD. Isolectin staining in adipose tissue
sections from LF-fed mice did not appear to be different between WT and eNOSTg transplanted groups (Figure 26A,B). In high fat-fed groups, isolectin staining
appeared to be significantly increased in adipose tissue of mice that received
eNOS-Tg bone marrow compared to WT (Figure 26C,D). In HF eNOS-Tg
adipose tissue sections, formation of large vascular networks are visualized by
positive isolectin staining which was not observed in any of the other groups.
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Figure 25
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Figure 25. Quantification of progenitor cell populations of the visceral
adipose tissue. Adipocyte progenitor cell, (A), and endothelial progenitor cell,
(B), populations are quantified as cells per gram tissue. The ratio of these two
cells types is presented in graph (C). CD34+ hematopoietic stem cells were also
quantified as cells per gram tissue, (D); n=9-10 mice/ group, *p<0.05 and
***p<0.001 vs. LF WT.
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Figure 26
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Figure 26. Isolectin staining of visceral adipose tissue sections after 12
weeks of LFD or HFD. Representative images of adipose tissue stained for
isolectin, perilipin, and DAPI are presented in the figure; LF WT, LF eNOS-Tg,
HF WT, and HF eNOS-Tg are represented by figures (A), (B), (C), and (D),
respectively. White arrows mark isolectin positive cells.
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Discussion
Major findings of this study show that increased expression of eNOS by
bone marrow cells promotes vascularization of adipose tissue under conditions of
nutrient excess. We also observed an increase in vascularization of
subcutaneous and visceral adipose tissue upon direct cell transplantation of bone
marrow-derived EPCs. In association with insulin resistance and glucose
intolerance occurring in mice fed HFD, we also observed a significant decrease
in adipose tissue EPCs. Since it has been shown that vascular dysfunction and
decreased nitric oxide may precede insulin resistance (109), we decided to
perform a bone marrow transplant experiments to determine if increasing NO in
bone marrow cells would promote favorable adipose tissue remodeling in
conditions of nutrient excess. This study revealed a significant increase in APC to
EPC ratio in all groups compared to WT LFD, due to a marked decline in Sca-1+
Flk1+ EPCs after 12 weeks of HFD and unchanged APC population. This
supports our previous work suggesting that the imbalance of progenitor cell
populations in the adipose tissue is diet dependent. It is also important to note
that CD34 positive cells, which have also been identified as an endothelial
progenitor populations (75, 79, 169, 170, 198), were significantly decreased with
HFD. Despite a marked increase in total body mass and a decreased number of
EPCs, mice transplanted with eNOS-Tg bone marrow showed an apparent
increase in vascularity of adipose tissue with HFD.
As previously discussed, NO has been shown to regulate differentiation of
adipocyte progenitors (79, 197, 199) and is significantly decreased with obesity
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(109). Repopulation of bone marrow with cells from mice overexpressing eNOS
was intended to increase NO bioavailability and promote the formation of more
vascularized capillary networks in adipose tissue. Our results show that
vascularity of adipose tissue is significantly increased in HF-fed mice after
transplantation of eNOS-Tg bone marrow cells, providing support for our
hypothesis. This suggests that increasing eNOS may encourage the
differentiation of progenitor cells in the adipose tissue to differentiate towards an
endothelial lineage with HFD. If progenitors in the adipose tissue are in fact
differentiating, this may account for the observed decrease we see upon analysis
of the SVF.
Though there have been numerous studies examining the contribution of
EPCs to angiogenesis (75, 79, 169) and APCs to adipogenesis (35, 37, 66), not
much is has been reported about the significance of the ratio of adipocyte and
endothelial progenitor cells in the context of adipose tissue remodeling. In this
study, we examined how correcting the imbalance of these two cell populations
in obese mice might impact adipose tissue remodeling. To counter the increase
in bone marrow-derived APCs we observed in mice fed HFD, we increased the
total EPC population in adipose tissue of obese mice by way of direct adipose
tissue cell transplantation. The average adipocyte area was not changed,
however engraftment of GFP positive donor cells into vasculature of
subcutaneous and visceral adipose tissue was evident 10 days after injection of
bone marrow-derived EPCs. Prior to injection, EPCs were cultured for several
days under normoxic conditions. Exposure of bone marrow-derived stem cells to
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normoxic conditions has been shown to encourage differentiation (41). Perhaps,
this “priming” of the transplanted bone marrow cells, increased their capacity to
differentiate and incorporate into the vasculature in vivo.
Accurate identification of endothelial progenitor cells is a limitation which
will hopefully be addressed by future studies in this field. Several different
endothelial progenitor populations are currently being studied and collectively,
these cells are referred to as “EPCs” because of the pro-angiogenic nature of the
cell type (68, 69, 71, 78, 80, 168, 170, 200). In mice, Sca-1+ Flk1+ cells are
considered to be EPCs (69, 71). However, this characterization may not include
all pro-angiogenic progenitor populations. More precise identification of murine
EPCs would be helpful in determining which specific progenitor populations are
contributing to adipose tissue remodeling and may be beneficial in the discovery
of interventions and therapies to treat obesity.
In summary, our work provides insight into the role that stem cells play in
the vascularization of adipose tissue during obesity. Through our work we were
able to show that an acute increase in bone marrow-derived progenitor cells in
adipose tissue of obese mice results in the engraftment of donor cells into
existing vasculature and new capillary networks. This could help correct the stem
cell imbalance occurring in obesity or prime stem cells to differentiate. Our data
also show that a long-term increase in eNOS, established by bone marrow
transplantation, increases vascularity in adipose tissue of high fat-fed mice.
Perhaps NO is important in the regulation of stem cells during conditions of
nutrient excess.
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CHAPTER 5
CONCLUDING DISCUSSION

The purpose of this dissertation was to understand better how adipose
tissue remodels to accommodate excess nutrients during obesity. The most
common cause for the development of obesity is hyperphagia resulting in the
consumption of an increased amount of calories from fat (13-15). With this in
mind, we used a nutrient excess model of obesity and examined structural,
metabolic and compositional changes that occur in white adipose tissue during
the development of obesity.
Evidence in the literature supports two forms of adipose tissue
remodeling—a pathologic form, which appears to be the default during white
adipose tissue expansion, and a protective form that allows for increased fat
storage capacity and maintains systemic insulin sensitivity (15, 62, 63).
Adipocyte hypertrophy, insulin resistance, adipose tissue inflammation, and
hypoxia are known to be associated with pathological expansion. Protective
remodeling is characterized by proliferation of adipocyte progenitors in lieu of
adipocyte hypertrophy. This type of remodeling allows for the preservation of
metabolic homeostasis and insulin sensitivity; yet, why protective adipose tissue
remodeling is not the default expansion method in diet-induced obesity remains
unclear. The studies presented in this manuscript were completed in an effort to
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investigate the mechanisms by which nutrient excess affects the adipose organ.
We hypothesize that obesity impairs stem cell-mediated adipose tissue
remodeling.
Prior to assessing this hypothesis directly, we first characterized the
metabolic changes that occur in adipose tissue during obesity. This is important
because metabolic changes and metabolites are now recognized as signaling
mediators that regulate cell and tissue dynamics. To observe global metabolic
changes after consumption of HFD, we completed several whole body
physiological assessments as well as metabolomic analysis of adipose tissue. As
described in Chapter 2, 6 weeks of HFD was sufficient to cause a marked
increase in body fat composition as measured by Dexascan and an overall
decline in physical activity was confirmed by metabolic cage analysis revealing
decreased ambulatory and fine movements in mice consuming HFD. An increase
in adipocyte area paired with substantial fat mass accumulation compared to
LFD led us to investigate the metabolic changes in visceral adipose tissue after 6
and 12 weeks of HF-feeding.
Consumption of HFD has been shown to decrease mitochondrial
abundance in adipose tissue (47-49). Our data showed that relative
mitochondrial abundance was not different in mice fed HFD for 6 weeks
compared to LF-fed group, however citrate synthase activity was decreased
more than 2 fold. This enzyme is anchored to the mitochondrial matrix and is
used in the Citric Acid Cycle for the conversion of acetyl-coA to citrate. Our
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results suggest that a decrease in citrate synthase activity may precede overt
diminishment of mitochondria.
Insulin sensitizing drugs such as thiazolidinediones (TZDs) like
pioglitazone and rosiglitazone have been shown to blunt this loss of mitochondria
and even increase mitochondrial function in adipose tissue of obese individuals
(49, 102). Interestingly, the role of TZDs has been examined in the context of
stem cell biology. There is disagreement in the field about whether TZDs mediate
the recruitment of bone marrow-derived cells to adipose tissue with consumption
of HFD. Pioglitazone has been shown to decrease adipose tissue inflammation
and adipose tissue macrophage accumulation induced by HFD (201). It was
reported that rosiglitazone treatment encouraged engraftment of bone marrowderived cells in adipose tissue. This engraftment of bone marrow derived cells
could also be seen to a lesser degree after feeding mice HFD. Data provided in
this study suggest that the engrafted cells were multilocular in morphology and
did not express CD11b or CD45, inflammatory cell markers (202). The next year,
these results were countered suggesting that bone marrow-derived cells do not
differentiate into adipocytes in vivo. Results of this study show that bone marrowderived cells accumulate in the interstitial space between adipocytes with HFD.
These cells expressed CD11b, F4/80, LYVE-1 and CD45 indicating that these
cells are most likely inflammatory cells (203). The major difference between
these studies was the treatment with rosiglitazone. Perhaps TZDs not only
impact mitochondrial abundance in mature adipocytes, but also promote
adipogenic differentiation of bone marrow derived cells.
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Our studies revealed that high fat diet induces the recruitment of bone
marrow-derived adipocyte progenitor cells to visceral adipose tissue after 12
weeks of HFD in the absence of pharmacological interventions. Characterization
of these cells revealed that the bone marrow-derived population was not
homogeneous. Characterization of SVF isolated from visceral adipose tissue
showed more than 96% of the total APC population was derived from the bone
marrow and approximately 20% of EPCs were bone marrow derived. However,
upon analysis of intact adipose tissue, we did not observe any mature adipocytes
which formed from the differentiation of a bone marrow-derived APC. We did
however observe the engraftment of bone marrow-derived EPCs into vasculature
of adipose tissue. Perhaps the metabolic changes in the adipose in response to
HFD suppress the capacity of APCs to differentiate in conditions of nutrient
excess.
One of the most robust changes that we observed via metabolomic
analysis of visceral white adipose tissue of HF-fed mice was an increase in
succinate. Succinate is an intermediate in the Citric Acid Cycle. The conversion
of succinate to fumarate is catalyzed by Complex II, succinate dehydrogenase.
This complex is composed of 4 subunits and after consumption of HFD for 12
weeks, the abundance of one component, succinate dehydrogenase B (SDHB),
was significantly decreased. Succinate dehydrogenase has been shown to
impact cell differentiation and proliferation. One such study showed mutations of
the gene encoding for succinate dehydrogenase have been shown to be
associated with normal citrate synthase levels, reduced oxygen consumption,
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and increase in HIF1-α which together increase cell migration and proliferation
(204). HIF1-α has been shown to increase with obesity (58, 205). Succinate has
also been shown to bind Gpr91, a Gi-coupled GPCR that regulates adipocyte
function, and activate it (206). Upon binding its receptor in white adipose tissue,
succinate inhibits lipolysis in adipocytes in vitro. (145). Perhaps the environment
created by nutrient excess impacts the differentiation of bone marrow-derived
APCs or the proliferation of tissue-resident EPCs.
In our assessment of the composition of the SVF isolated from HF-fed
mice, we did not observe statistically significant changes in the number of APCs
and EPCs. However, their relative abundance was changed, i.e., the ratio of
APCs to EPCs was increased more than 5-fold with HFD. Since both endothelial
and adipocyte progenitors are necessary for adipose tissue to expand in a
metabolically favorable manner, the imbalance of these cell types could be
critical for favorable adipose tissue remodeling.
As previously described, HFD is associated with a host of metabolic
changes in adipose tissue which can lead to mitochondrial dysfunction. Since NO
is a major regulator of mitochondrial biogenesis (207, 208) which is decreased
with obesity, we experimented with increasing NO bioavailability under conditions
of nutrient excess in the hope of generating a more perfused vascular network in
the adipose tissue of obese mice. Interestingly, we found that HFD leads to a
slightly greater increase in body mass of eNOS-Tg mice compared with WT
transplanted mice. However, this did not induce changes in glucose tolerance,
insulin tolerance, or stem cell abundance in adipose tissue compared to WT
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transplanted groups. Perhaps increasing NO via this route, i.e., via bone-marrow,
is not advantageous to the adipose tissue remodeling process, or it is possible
that conditions of HFD lead to eNOS uncoupling, which is in line with our
previous findings (Sansbury Circ Res 2012). With regard to the former, this may
be expected, as most of the EPCs in adipose tissue are resident to the tissue.
In chapter 4, we sought to determine the contribution of stem cells to
adipose tissue remodeling. Since the ratio of APC to EPC was significantly
increased with HFD, we chose to correct the imbalance of these cells via direct
transplantation of EPCs into adipose tissue. This was specifically aimed to
determine if supplementation of the deficient population could improve insulin
and glucose handling. After just 10 days there was an observable increase in
donor cell engraftment into capillary networks of the adipose tissue, indicating
that the proportion of these progenitor cells may be important to the adipose
remodeling process.
Engraftment of transplanted stem cells is a major issue in the field (209213), and culture conditions between cell isolation and transplant could modify
cell competency. For example, exposure of bone marrow-derived stem cells to
increased oxygen levels for 5 days has been shown to be sufficient to promote
survival, growth, and cell migration when cells are reintroduced to hypoxia (214).
Since bone marrow-derived EPCs were primed in a normoxic culture
environment prior to injection, perhaps the cells were preconditioned to
differentiate and contribute to vascular stability in vivo.
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In summary, these studies provide new and essential understanding for
how conditions of obesity affect adipose tissue stem cells and adipose tissue
remodeling. We find that diet-induced pathological adipose tissue remodeling is
characterized by increased numbers of bone marrow-derived APCs and an
increase in the APC to EPC ratio. We also find that APCs are derived
predominantly from the bone marrow, whereas EPCs appear to be primarily
resident to adipose tissue. Hence, metabolic changes occurring in the adipose
organ during obesity could have a greater effect on tissue resident cells, such as
EPCs. In line with this finding, BrdU staining in tissue-resident stromal cells of
high fat-fed animals was lower than that of low fat-fed counterparts, which may
be indicative of impaired EPC competency. Transplantation of EPCs directly into
adipose tissue increased isolectin positivity, suggesting that they could increase
vascular density, and this was augmented further when the EPCs overexpressed
eNOS. Collectively, these studies demonstrate that obesity-induced
derangement of adipose tissue stem cells in white adipose tissue is a modifiable
target to combat obesity and its associated co-morbidities. Exciting prospects for
future studies include addressing the potential metabolic underpinnings of
obesity-related changes in adipose tissue stem cells and determining how
restoration of stem cell competency affects obesity and its associated
complications.
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